References - Neurology

^ a b c BBC NEWS | UK | Magazine | Sense and scent ability
^ http://web.archive.org/web/20060101000005/http://www.coldcure.com/anosmia/anosmia.html
^ Doty RL, Mishra A (2001). "Influences of nasal obstruction, rhinitis, and rhinosinusitis on the ability to smell". Laryngoscope 111: 409–23. 
^ Doty RL, Yousem DM, Pham LT, Kreshak AA, Lee WW (1997). "Olfactory dysfunction in patients with head trauma". Arch Neurol 54: 1131–1140. 
^ Doty RL, Deems D, Stellar S (1988). "Olfactory dysfunction in Parkinson's disease: A general deficit unrelated to neurologic signs, disease stage, or disease duration". Neurology 38: 1237–44. 
^ Murphy C (1999). "Loss of olfactory function in dementing disease". Physiology & Behavior 66: 177–182. doi:10.1016/S0031-9384(98)00262-5. 
^ Schwartz B, Doty RL, Frye RE, Monroe C, Barker S (1989). "Olfactory function in chemical workers exposed to acrylate and methacrylate vapors". Am J Pub Health 79: 613–618. doi:10.2105/AJPH.79.5.613. 
^ Rose CS, Heywood PG, Costanzo RM (1992). "Olfactory impairment after chronic occupational cadmium exposure". Journal of Occupational Medicine 34: 600–605. 
^ Rydzewski B, Sulkowski W, Miarzynaska M (1998). "Olfactory disorders induced by cadmium exposure: A clinical study". Int J Occ Med Env Health 11: 235–245. 
^ Doty RL, Shaman P, Applebaum SL, Giberson R, Sikorsky L, Rosenberg L (1984). "Smell identification ability: Changes with age". Science 226: 1441–1443. doi:10.1126/science.6505700. PMID 6505700. 
^ eMedicine - Esthesioneuroblastoma : Article by Pavel Dulguerov
^ [http://www.sport-magazine.co.uk/Football/Harry-Redknapp-interview.html
^ [1]
·  ^ a b International Council of Ophthalmology. "International Standards: Visual Standards — Aspects and Ranges of Vision Loss with Emphasis on Population Surveys." April 2002.

·  ^ Belote, Larry. "Low Vision Education and Training: Defining the Boundaries of Low Vision Patients." A Personal Guide to the VA Visual Impairment Services Program. Retrieved March 31, 2006.

·  ^ Living with Low Vision - American Foundation for the Blind

·  ^ http://www3.who.int/icd/currentversion/fr-icd.htm

·  ^ WHO | Magnitude and causes of visual impairment

·  ^ a b Koestler, F. A., (1976). The unseen minority: a social history of blindness in the United States. New York: David McKay.

·  ^ Corn, AL; Spungin, SJ. "Free and Appropriate Public Education and the Personnel Crisis for Students with Visual Impairments and Blindness." Center on Personnel Studies in Special Education. April 2003.

·  ^ http://www.ssa.gov/history/pdf/80chap12.pdf

·  ^ Social Security Act. "Sec. 1614. Meaning of terms." Retrieved February 17, 2006.

·  ^ Al-Merjan JI, Pandova MG, Al-Ghanim M, Al-Wayel A, Al-Mutairi S. "Registered blindness and low vision in Kuwait." Ophthalmic Epidemiol. 2005 Aug;12(4):251-7. PMID 16033746.

·  ^ a b Kirchner, C., Stephen, G. & Chandu, F. (1987). "Estimated 1987 prevalence of non-institutionalized 'severe visual impairment' by age base on 1977 estimated rates: U. S.", 1987. AER Yearbook.

·  ^ American Foundation for the Blind. "Statistics and Sources for Professionals." Retrieved April 1, 2006.

·  ^ "World Health Organization" (Web). World Health Organization. 2006. http://www.who.int/en/. Retrieved on December 16 2006. 

·  ^ "Causes of blindness and visual impairment". World Health Organization. http://www.who.int/blindness/causes/en/. Retrieved on 19 February 2009. 

·  ^ Bunce C, Wormald R. "Leading Causes of Certification for Blindness and Partial Sight in England & Wales." BMC Public Health. 2006 March 8;6(1):58 [Epub ahead of print]. PMID 16524463.

·  ^ "Methanol" (Web). Symptoms of Methanol Poisoning. Canada Safety Council. 2005. http://www.safety-council.org/info/OSH/methanol.htm. Retrieved on March 27 2007. 

·  ^ "Eye-for-eye in Pakistan acid case". BBC News. 12 December, 2003. http://news.bbc.co.uk/2/hi/south_asia/3313207.stm. Retrieved on 2008-06-30. 

·  ^ Bainbridge JW, Smith AJ, Barker SS, et al (May 2008). "Effect of gene therapy on visual function in Leber's congenital amaurosis". N. Engl. J. Med. 358 (21): 2231–9. doi:10.1056/NEJMoa0802268. PMID 18441371. http://content.nejm.org/cgi/content/abstract/NEJMoa0802268. 

·  ^ Accessibility features - Bank Notes - Bank of Canada

·  ^ "Blind Sports Victoria". http://www.blindsports.org.au/. Retrieved on 2008-03-04. 

·  ^ "IBSA General Assembly Elects New Leadership". The Paralympian. International Paralympic Committee. April 2001. http://www.paralympic.org/paralympian/20014/2001430.htm. Retrieved on 2008-03-04. 

·  ^ "The history of people with disabilities in Australia - 100 years". Disability Services Australia. http://www.dsa.org.au/life_site/text/sport/index.html. Retrieved on 2008-03-04.

^ "Speech and Language Terms and Abbreviations". http://www.oafccd.com/factshee/fact59.htm. Retrieved on 2006-12-02. 
^ eBook: Current Diagnosis & Treatment in Otolaryngology: Head & Neck Surgery, Lalwani, Anil K. (Ed.) Chapter 44: Audiologic Testing by Robert W. Sweetow, PhD, Jennifer McKee Bold, AuD, Access Medicine
^ http://www.eeoc.gov/facts/deafness.html Hearing impairment and the Americans with Disabilities Act
^ Tim Grieve (October 7, 2003). "Did popping painkillers make Rush lose his hearing?". Salon.com. http://dir.salon.com/story/news/feature/2003/10/07/rush_drugs/index.html. Retrieved on 2008-09-08. 
^ Elliot & Oliver'S Story - Research
^ Andy Coghlan (2005-02-14). "Gene therapy is first deafness 'cure'". NewScientist.com News Service. http://www.newscientist.com/article.ns?id=dn7003. 
^ PMID 18754012
^ dizziness at Dorland's Medical Dictionary
^ MeSH Dizziness
^ "Dizziness - Definition from the Merriam-Webster Online Dictionary". http://www.merriam-webster.com/dictionary/Dizziness. 
^ vertigo at Dorland's Medical Dictionary
·  ^ "Dyspraxia Info". http://www.rdg.ac.uk/studyskills/dyslexia/dyspraxia%20info.htm. Retrieved on 2008-04-05. 

·  ^ Dewey D (1995). "What is developmental dyspraxia?". Brain Cogn 29 (3): 254–74. doi:10.1006/brcg.1995.1281. PMID 8838385. http://linkinghub.elsevier.com/retrieve/pii/S0278-2626(85)71281-X. 

·  ^ Jenny Barrett; Kate Ripley; Bob Daines (1997). Dyspraxia : A Guide For Teachers and Parents (Resource Materials for Teachers). David Fulton Publishers, Ltd. pp. 3. ISBN 1-85346-444-9. 

·  ^ Kirby, Amanda; Davies, Rhys; Bryant, Amy (2005-11), Do teachers know more about specific learning difficulties than general practitioners?, British Journal of Special Education, http://www.ingentaconnect.com/content/bpl/bjsp/2005/00000032/00000003/art00003 

·  ^ Pam Williams, Developmental Verbal Dyspraxia, Nuffield Hearing & Speech Centre

·  ^ "Dyspraxia". http://www.childlearningdifficulties.com/Dysprraxiaind.htm. Retrieved on 2008-04-05. 

·  ^ "Amanda Kirby speaking to dysTalk on the co-occurrence of learning difficulties". http://www.dystalk.com/talks/57-co-occurrence-of-learning-difficulties. Retrieved on 2009-04-22. 

·  ^ "Dyspraxia Adults Action". http://www.colsal.org.uk/sites/daa/THEGIFTOFDYSPRAXIA.asp. Retrieved on 2008-04-05. 

·  ^ a b "What is Dyspraxia". http://www.dyspraxia.org.nz/what_is.htm. Retrieved on 2008-04-05.

Haines, Duane (2004). Neuroanatomy: an atlas of structures, sections, and systems. Hagerstown, MD: Lippincott Williams & Wilkins. ISBN 0-7817-4677-9. 
Duffy, Joseph R (2005). Motor Speech Disorders: Substrates, Differential Diagnosis, And Management. 2nd edition.. Saint Louis: C.V. Mosby. ISBN 0-323-02452-1. 
http://content.nejm.org/cgi/content/full/345/1/17
^ B.E. Murdoch: Acquired Neurological Speech/Language Disorders in Childhood: Language Disorders in Childhood (1990)
^ a b B.T. Woods: Acquired Childhood Aphasia, in: H.S. Kirshner: Handbook of neurological speech and language disorders (1994).
^ P.F. Paquier & H.R. van Dongen: Is Acquired Childhood Aphasia Atypical? In: P. Coppens et al.: Aphasia in Atypical Populations (1998)
^ D.P: Cantwell: Developmental Speech and Language Disorders (1987)
^ Kolb & Whishaw: Fundamentals of Human Neuropsychology (2003), page 502, 505, 511.
^ Kolb & Whishaw: Fundamentals of Human Neuropsychology (2003), pages 502-504. The whole paragraph "fluent, non-fluent and pure aphasias" is written with help of this reference.
^ http://christofflab.psych.ubc.ca/psych260/docs/L12-Language.pdf
^ Paul R. McCrory and Samuel F. Berkovic (2001). Concussion: The history of clinical and pathophysiological concepts and misconceptions. Neurology, 57(12): 2283-2289. PMID 11756611.
^ Richardson, Robert D. Jr. Emerson: The Mind on Fire. Berkeley, California: University of California Press, 1995: 569. ISBN 0-520-08808-5.
http://en.wikipedia.org/wiki/Drop_attack

^ American Family Physician, March 1, 2003 Delirium
^ Teng E L, Chui H C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314–18. PMID 3611032
^ Teng E L, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45–58. PMID 8054493
^ Royall, D.; Cordes J.; & Polk M. (1998). "CLOX: an executive clock drawing task". J Neurol Neurosurg Psychiatry 64 (5): 588–94. doi:10.1136/jnnp.64.5.588. PMID 9598672. http://jnnp.bmj.com/cgi/content/full/64/5/588. 
^ Boustani, M.; Peterson, B.; Hanson, L.; Harris, R.; & Lohr, K. (03 Jun 2003). "Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force". Ann Intern Med 138 (11): 927–37. PMID 12779304. http://www.annals.org/cgi/content/full/138/11/927. 
^ "Appendix: The Modified Mini-Mental State (3MS)". http://www.cjns.org/27febtoc/predicting_appendix_.html. Retrieved on 2007-09-06. 
^ a b Cullen B, O'Neill B, Evans JJ, Coen RF, Lawlor BA. A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):790-9. Epub 2006 Dec 18. PMID 17178826
^ Sager, M.; Hermann, B.; La Rue, A.; & Woodard, J. (2006). "Screening for dementia in community-based memory clinics". WMJ 105 (7): 25–9. PMID 17163083. 
^ Fleisher, A.; Sowell B.; Taylor C.; Gamst A.; Petersen R.; & Thal L. (2007). "Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment". Neurology 68: 1588. doi:10.1212/01.wnl.0000258542.58725.4c. PMID 17287448. 
^ Karlawish, J. & Clark, C. (2003). "Diagnostic evaluation of elderly patients with mild memory problems". Ann Intern Med 138 (5): 411–9. PMID 12614094. http://www.annals.org/cgi/content/full/138/5/411. 
^ Jorm, A.F. (2004). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): A review. International Psychogeriatrics, 16, 1-19.
^ Bonte, FJ; Harris TS, Hynan LS, Bigio EH, White CL 3rd (July 2006). "Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation". Clinical Nuclear Medicine 31 (7): 376–8. doi:10.1097/01.rlu.0000222736.81365.63. PMID 16785801. 
^ Dougall, NJ; Bruggink S, Ebmeier KP (Nov-December 2004). "Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia". The American Journal of Geriatric Psychiatry 12 (6): 554–70. doi:10.1176/appi.ajgp.12.6.554. PMID 15545324. 
^ "Bilingualism Has Protective Effect In Delaying Onset Of Dementia By Four Years, Canadian Study Shows". Medical News Today. 2007-01-11. http://www.medicalnewstoday.com/medicalnews.php?newsid=60646. Retrieved on 2007-01-16. 
^ Aldridge, David, Music Therapy in Dementia Care, London : Jessica Kingsley Publishers, November 2000. ISBN 1853027766
^ Tuet, R.W.K.; Lam, L.C.W. (September 2006) "A preliminary study of the effects of music therapy on agitation in Chinese patients with dementia", Hong Kong Journal of Psychiatry, Volume 16, Number 3
^ Watanabe, Tomoyuki; et al., "Effects of music therapy for dementia: A systematic review", (in Japanese) Aichi University of Education Research Reports, v.55, pp. 57-61, March, 2005
^ Koger, Susan M.; Chapin Kathyn; Brotons, Melissa, "Is Music Therapy an Effective Intervention for Dementia? : A Meta-Analytic Review of Literature", Journal of Music Therapy 36(1), February 1999, pp.2-15.
^ Remington, Ruth, "Calming Music and Hand Massage With Agitated Elderly", Nursing Research 51(5): 317-323, September/October 2002.
^ Lleo A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer's disease. Annu Rev Med. 2006;57:513-33. Review. PMID 16409164
^ Choi, Y., Kim, H.S., Shin, K.Y., Kim, E.M., Kim, M., Kim, H.S., Park, C.H., Jeong, Y.H., Yoo, J., Lee, J.P., Chang K.A., Kim S., & Suh, Y.H. Related Minocycline Attenuates Neuronal Cell Death and Improves Cognitive Impairment in Alzheimer's Disease Models. Neuropsychopharmacology. 2007 Apr 4; PMID 17406652
^ "FDA MedWatch - 2008 Safety Alerts for Human Medical Products". FDA. http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antipsychotics. 
^ "FDA MedWatch - 2008 Safety Alerts for Human Medical Products". FDA. http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antipsychotics. 
^ Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT, Mittleman MA, Siscovick DS (March 2003). "Prospective study of alcohol consumption and risk of dementia in older adults". JAMA 289 (11): 1405–13. doi:10.1001/jama.289.11.1405. PMID 12636463. 
^ Ganguli M, Vander Bilt J, Saxton JA, Shen C, Dodge HH (October 2005). "Alcohol consumption and cognitive function in late life: a longitudinal community study". Neurology 65 (8): 1210–7. doi:10.1212/01.wnl.0000180520.35181.24. PMID 16247047. 
^ Huang W, Qiu C, Winblad B, Fratiglioni L (October 2002). "Alcohol consumption and incidence of dementia in a community sample aged 75 years and older". J Clin Epidemiol 55 (10): 959–64. doi:10.1016/S0895-4356(02)00462-6. PMID 12464371. 
^ Sofi F, Cesari F, Abbate R, Gensini GF, Casini A (2008). "Adherence to Mediterranean diet and health status: meta-analysis". BMJ 337: a1344. doi:10.1136/bmj.a1344. PMID 18786971. 
^ Fillit H, Nash DT, Rundek T, Zuckerman A (June 2008). "Cardiovascular risk factors and dementia". Am J Geriatr Pharmacother 6 (2): 100–18. doi:10.1016/j.amjopharm.2008.06.004. PMID 18675769. 
^ Peters R, Beckett N, Forette F, et al (August 2008). "Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial". Lancet Neurol 7 (8): 683–9. doi:10.1016/S1474-4422(08)70143-1. PMID 18614402. 
^ Drivers with dementia a growing problem, MDs warn, CBC News, Canada, September 19, 2007
^ Gait Abnormality Coding Checklist by Jun Mapili, PT, MAEd
^ ICD-9-cm Chrisenders
·  ^ Levine et al., p 60

·  ^ "216.25.100.131" (PDF). the Headache Classification Subcommittee of the International Headache Society. http://216.25.100.131/ihscommon/guidelines/pdfs/ihc_II_main_no_print.pdf. 

·  ^ Olsen et al., p. 9–11

·  ^ BROWN MR (September 1951). "The classification and treatment of headache". Med. Clin. North Am. 35 (5): 1485–93. PMID 14862569. 

·  ^ Jes Olesen, Peter J. Goadsby, Nabih M. Ramadan, Peer Tfelt-Hansen, K. Michael A. Welch (2005). The Headaches (3 ed.). Lippincott Williams & Wilkins. ISBN 0781754003. 

·  ^ Morris Levin, Steven M. Baskin, Marcelo E. Bigal (2008). Comprehensive Review of Headache Medicine. OxfordUniversity Press US. ISBN 0195366735. 

·  ^ Levine et al., p 60

·  ^ a b c d Edlow JA, Panagos PD, Godwin SA, Thomas TL, Decker WW (October 2008). "Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache". Ann Emerg Med 52 (4): 407–36. doi:10.1016/j.annemergmed.2008.07.001. PMID 18809105. 

·  ^ Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM. Does this patient with headache have a migraine or need neuroimaging? JAMA 2006;296:1274–83

·  ^ Brain Stimulation May Ease Headaches. Reuters, March 9, 2007.

·  ^ Sun Y, Gan TJ (December 2008). "Acupuncture for the management of chronic headache: a systematic review". Anesth. Analg. 107 (6): 2038–47. doi:10.1213/ane.0b013e318187c76a. PMID 19020156.

·  ^ ICD9Data.com - Diagnosis Codes, Meningismus

·  ^ a b Thomas KE, Hasbun R, Jekel J, Quagliarello VJ (2002). "The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis". Clin. Infect. Dis. 35 (1): 46–52. doi:10.1086/340979. PMID 12060874. http://www.journals.uchicago.edu/doi/full/10.1086/340979. 

·  ^ Kernig VM (1882). "Ein Krankheitssymptom der acuten Meningitis". St Petersb Med Wochensch 7: 398. 

·  ^ O'Connor, Simon; Talley, Nicholas Joseph (2001). Clinical Examination: A Systematic Guide to Physical Diagnosis. Cambridge, MA: Blackwell Publishers. p. 363. ISBN 0-632-05971-0. 

·  ^ Brudzinski J (1909). "Un signe nouveau sur les membres inférieurs dans les méningites chez les enfants (signe de la nuque)". Arch Med Enf 12: 745–52. 

·  ^ doctor/2299 at Who Named It?

·  ^ a b Brudzinski J (1916). "Über neue Symptome von Gehirnhautentzündung und -reizung bei Kindern, insbesondere bei tuberkulösen". Berl Klin Wochensch 53: 686–90. 

·  ^ Brudzinski J (1908). "Über die kontralateralen Reflexe an den unteren Extremitäten bei Kindern". Wien Klin Wochensch 8: 255–61.

^ "Myopathy - Definition from the Merriam-Webster Online Dictionary". http://www.merriam-webster.com/dictionary/Myopathy. 
·  ^ neuropathy at Dorland's Medical Dictionary

·  ^ "eMedicine/Stedman Medical Dictionary Lookup!". http://www.emedicine.com/asp/dictionary.asp?keyword=Neuropathy. Retrieved on 2008-11-30. 

·  ^ Dyck PJ (1982). "Current concepts in neurology. The causes, classification, and treatment of peripheral neuropathy". N. Engl. J. Med. 307 (5): 283–6. PMID 6283352. 

·  ^ http://www.neurologychannel.com/neuropathy/symptoms.shtml

·  ^ Bogduk, Nikolai; Merskey, Harold (1994). Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms (2nd edition ed.). Seattle: IASP Press. pp. 212. ISBN 0931092051. 

·  ^ Torrance N, Smith BH, Bennett MI, Lee AJ (April 2006). "The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey". J Pain 7 (4): 281–9. doi:10.1016/j.jpain.2005.11.008. PMID 16618472. 

·  ^ Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C (June 2008). "Prevalence of chronic pain with neuropathic characteristics in the general population". Pain 136 (3): 380–7. doi:10.1016/j.pain.2007.08.013. PMID 17888574. 

·  ^ Dworkin RH, Fields HL (2005). "Fibromyalgia from the perspective of neuropathic pain". J Rheumatol Suppl 75: 1–5. PMID 16078355. http://www.jrheum.com/subscribers/05/75/1.html. 

·  ^ Portenoy RK (1989). "Painful polyneuropathy". Neurol Clin 7 (2): 265–88. PMID 2566901. 

·  ^ Vaillancourt PD, Langevin HM (1999). "Painful peripheral neuropathies". Med. Clin. North Am. 83 (3): 627–42, vi. doi:10.1016/S0025-7125(05)70127-9. PMID 10386118. 

·  ^ [1] Chemotherapy-induced Peripheral Neuropathy Fact Sheet, Retrieved on 29-Dec-2008

·  ^ [2] Cancerbackup, Macmillan Cancer Support, Peripheral neuropathy, Retrieved on 29-Dec-2008

·  ^ Guddin, J.A. Expanding Our Understanding of Central Sensitization. 'Medscape1994-2008. [3].

·  ^ Wieseler-Frank J, Maier SF, Watkins LR (2005). "Central proinflammatory cytokines and pain enhancement". Neuro-Signals 14 (4): 166–74. doi:10.1159/000087655. PMID 16215299. 

·  ^ Truini A, Cruccu G (May 2006). "Pathophysiological mechanisms of neuropathic pain". Neurol. Sci. 27 Suppl 2: S179–82. doi:10.1007/s10072-006-0597-8. PMID 16688626. 

·  ^ Dworkin RH, O'Connor AB, Backonja M, et al (2007). "Pharmacologic management of neuropathic pain: evidence-based recommendations". Pain 132 (3): 237–51. doi:10.1016/j.pain.2007.08.033. PMID 17920770. 

·  ^ Attal N, Cruccu G, Haanpää M, et al (2006). "EFNS guidelines on pharmacological treatment of neuropathic pain". Eur. J. Neurol. 13 (11): 1153–69. doi:10.1111/j.1468-1331.2006.01511.x. PMID 17038030. 

·  ^ MoulinDE, Clark AJ, Gilron I, et al (2007). "Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society". Pain Res Manag 12 (1): 13–21. PMID 17372630. 

·  ^ Bennett G, Xie Y (1988). "A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man". Pain 33 (1): 87–107. doi:10.1016/0304-3959(88)90209-6. PMID 2837713. 

·  ^ Seltzer Z, Dubner R, Shir Y. "A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury". Pain 43. doi:10.1016/0304-3959(90)91074-S. PMID 1982347. 

·  ^ Kim S, Chung J (1992). "An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat". Pain 50 (3): 355–63. doi:10.1016/0304-3959(92)90041-9. PMID 1333581. 

·  ^ Malmberg A, Basbaum A (1998). "Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates". Pain 76 (1-2): 215–22. doi:10.1016/S0304-3959(98)00045-1. PMID 9696476. 

·  ^ Sung B, Na H, Kim Y, Yoon Y, Han H, Nahm S, Hong S (1998). "Supraspinal involvement in the production of mechanical allodynia by spinal nerve injury in rats". Neurosci. Lett. 246 (2): 117–9. doi:10.1016/S0304-3940(98)00235-3. PMID 9627194. 

·  ^ Lee B, Won R, Baik E, Lee S, Moon C (2000). "An animal model of neuropathic pain employing injury to the sciatic nerve branches". Neuroreport 11 (4): 657–61. doi:10.1097/00001756-200003200-00002. PMID 10757496. 

·  ^ Decosterd I, Woolf C (2000). "Spared nerve injury: an animal model of persistent peripheral neuropathic pain". Pain 87 (2): 149–58. doi:10.1016/S0304-3959(00)00276-1. PMID 10924808. 

·  ^ Vadakkan K, Jia Y, Zhuo M (2005). "A behavioral model of neuropathic pain induced by ligation of the common peroneal nerve in mice". The journal of pain : official journal of the American Pain Society 6 (11): 747–56. PMID 16275599. 

·  ^ Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain.Cochrane Database Syst Rev. 2007;(2):CD006044.

·  ^ Davis AM, Inturrisi CE (1999). "d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia". J. Pharmacol. Exp. Ther. 289 (2): 1048–53. PMID 10215686. http://jpet.aspetjournals.org/cgi/content/full/289/2/1048. 

·  ^ Bruera E, Palmer JL, Bosnjak S, et al (2004). "Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study". J. Clin. Oncol. 22 (1): 185–92. doi:10.1200/JCO.2004.03.172. PMID 14701781. 

·  ^ Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR (1999). "Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation". Pain 81 (1-2): 135–45. doi:10.1016/S0304-3959(99)00007-X. PMID 10353501. 

·  ^ FinnerupNB, Otto M, Jensen TS, Sindrup SH (2007). "An evidence-based algorithm for the treatment of neuropathic pain". MedGenMed 9 (2): 36. PMID 17955091. 

·  ^ Ponto LL (May 2006). "Challenges of marijuana research". Brain 129 (Pt 5): 1081–3. doi:10.1093/brain/awl092. PMID 16627464. 

·  ^ Abrams D, Jay C, Shade S, Vizoso H, Reda H, Press S, Kelly M, Rowbotham M, Petersen K (2007). "Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial". Neurology 68 (7): 515–21. doi:10.1212/01.wnl.0000253187.66183.9c. PMID 17296917. 

·  ^ Frank B, Serpell MG, Hughes J, Matthews JN, Kapur D (2008). "Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study". BMJ 336 (7637): 199–201. doi:10.1136/bmj.39429.619653.80. PMID 18182416. 

·  ^ Campbell FA, Tramèr MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ (2001). "Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review". BMJ 323 (7303): 13–6. doi:10.1136/bmj.323.7303.13. PMID 11440935. 

·  ^ Wallace M, Schulteis G, Atkinson JH, et al (2007). "Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers". Anesthesiology 107 (5): 785–96. doi:10.1097/01.anes.0000286986.92475.b7 (inactive 2008-06-25). PMID 18073554. 

·  ^ "Sativex - Investigational Cannabis-Based Treatment for Pain and Multiple Sclerosis Drug Development Technology". www.drugdevelopment-technology.com. http://www.drugdevelopment-technology.com/projects/sativex/. Retrieved on 2008-08-08. 

·  ^ Vickers SP, Kennett GA (March 2005). "Cannabinoids and the regulation of ingestive behaviour". Curr Drug Targets 6 (2): 215–23. PMID 15777191. http://www.bentham-direct.org/pages/content.php?CDT/2005/. 

·  ^ Ranoux D, Attal N, Morain F, Bouhassira D (September 2008). "Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain". Annals of neurology 64 (3): 274–83. doi:10.1002/ana.21427. PMID 18546285. 

·  ^ Naumann M, So Y, Argoff CE, et al (May 2008). "Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the AmericanAcademy of Neurology". Neurology 70 (19): 1707–14. doi:10.1212/01.wnl.0000311390.87642.d8. PMID 18458231. 

·  ^ Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB (1997). "High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia". Neurology 48 (5): 1212–8. PMID 9153445. 

·  ^ Head KA (2006). "Peripheral neuropathy: pathogenic mechanisms and alternative therapies" (PDF). Altern Med Rev 11 (4): 294–329. PMID 17176168. http://www.thorne.com/altmedrev/.fulltext/11/4/294.pdf. 

·  ^ a b Foster TS (2007). "Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy". Diabetes Educ 33 (1): 111–7. doi:10.1177/0145721706297450. PMID 17272797. "ALA appears to improve neuropathic symptoms and deficits when administered via parenteral supplementation over a 3-week period. Oral treatment with ALA appears to have more conflicting data whether it improves sensory symptoms or just neuropathic deficits alone.". 

·  ^ Ziegler D, Ametov A, Barinov A, et al (2006). "Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial". Diabetes Care 29 (11): 2365–70. doi:10.2337/dc06-1216. PMID 17065669. 

·  ^ Patton LL, Siegel MA, Benoliel R, De Laat A (2007). "Management of burning mouth syndrome: systematic review and management recommendations". Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 Suppl: S39.e1–13. doi:10.1016/j.tripleo.2006.11.009. PMID 17379153. 

·  ^ Stracke H, Lindemann A, Federlin K (1996). "A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy". Exp. Clin. Endocrinol. Diabetes 104 (4): 311–6. PMID 8886748. 

·  ^ Thornalley PJ (2005). "The potential role of thiamine (vitamin B(1)) in diabetic complications". Curr Diabetes Rev 1 (3): 287–98. doi:10.2174/157339905774574383. PMID 18220605. 

·  ^ Chen H, Lamer TJ, Rho RH, et al (2004). "Contemporary management of neuropathic pain for the primary care physician". Mayo Clin. Proc. 79 (12): 1533–45. doi:10.4065/79.12.1533. PMID 15595338. 

·  ^ Kerns JW, White A, Nashelsky J, Sherman S (2006). "Does psychiatric treatment help patients with intractable chronic pain?". J Fam Pract 55 (3): 235–6. PMID 16510058. http://www.jfponline.com/Pages.asp?AID=3897. 

·  ^ Burke T. "Part 9. How Light (Photo Energy) May Increase Local NO and Vasodilation". Nitric Oxide and Its Role in Health and Diabetes. Diabetes In Control. http://www.diabetesincontrol.com/burkearchive/nitricoxide9.shtml. Retrieved on 2008-03-28. 

·  ^ Lavery LA, Murdoch DP, Williams J, Lavery DC (2008). "Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy". Diabetes Care 31 (2): 316–21. doi:10.2337/dc07-1794. PMID 17977931. 

·  ^ Krames ES. Neuromodulatory devices are part of our "Tools of the Trade". Pain Med 2006;7:S3-5.

·  ^ Turner JA, Loeser JD, Deyo RA, Sanders SB (2004). "Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications". Pain 108 (1-2): 137–47. doi:10.1016/j.pain.2003.12.016. PMID 15109517. 

·  ^ Lynch SS, Cheng CM, Yee JL (2006). "Intrathecal ziconotide for refractory chronic pain". Ann Pharmacother 40 (7-8): 1293–300. doi:10.1345/aph.1G584. PMID 16849624. 

·  ^ Turner JA, Sears JM, Loeser JD (2007). "Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications". Clin J Pain 23 (2): 180–95. doi:10.1097/01.ajp.0000210955.93878.44. PMID 17237668. 

·  ^ Brown JA, Pilitsis JG. Motor Cortex Stimulation Pain Medicine 2006; 7:S140.

·  ^ Osenbach, R. Neurostimulation for the Treatment of Intractable Facial Pain Pain Medicine 2006; 7:S126

·  ^ Bittar RG, Kar-Purkayastha I, Owen SL, et al (2005). "Deep brain stimulation for pain relief: a meta-analysis". J Clin Neurosci 12 (5): 515–9. doi:10.1016/j.jocn.2004.10.005. PMID 15993077. 

·  ^ Oh MY, Abosch A, Kim SH, Lang AE, Lozano AM (2002). "Long-term hardware-related complications of deep brain stimulation". Neurosurgery 50 (6): 1268–74; discussion 1274–6. doi:10.1097/00006123-200206000-00017. PMID 12015845.

·  ^ Serra A, Leigh RJ (December 2002). "Diagnostic value of nystagmus: spontaneous and induced ocular oscillations". J. Neurol. Neurosurg. Psychiatr. 73 (6): 615–8. doi:10.1136/jnnp.73.6.615. PMID 12438459. http://jnnp.bmj.com/cgi/pmidlookup?view=long&pmid=12438459. 

·  ^ Pierrot-Deseilligny C, Milea D (June 2005). "Vertical nystagmus: clinical facts and hypotheses". Brain 128 (Pt 6): 1237–46. doi:10.1093/brain/awh532. PMID 15872015. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=15872015. 

·  ^ Cole S, Nowaczyk RH (August 1994). "Field sobriety tests: are they designed for failure?". Percept Mot Skills 79 (1 Pt 1): 99–104. PMID 7991338. 

·  ^ Booker JL (2004). "The Horizontal Gaze Nystagmus test: fraudulent science in the American courts". Sci. Justice 44 (3): 133–9. doi:10.1016/S1355-0306(04)71705-0. PMID 15270451. 

·  ^ Booker JL (2001). "End-position nystagmus as an indicator of ethanol intoxication". Sci. Justice 41 (2): 113–6. doi:10.1016/S1355-0306(01)71862-X. PMID 11393940. 

·  ^ McKnight AJ, Langston EA, McKnightAS, Lange JE (May 2002). "Sobriety tests for low blood alcohol concentrations". Accid Anal Prev 34 (3): 305–11. doi:10.1016/S0001-4575(01)00027-6. PMID 11939359.

·  ^ "nystagmus". http://www.drhull.com/EncyMaster/N/nystagmus.html. Retrieved on 2007-06-07. 

·  ^ "American Nystagmus Network-About Nystagmus". http://www.nystagmus.org/aboutn.html. Retrieved on 2007-06-07. 

·  ^ Anagnostou E, Mandellos D, Limbitaki G, Papadimitriou A, Anastasopoulos D (June 2006). "Positional nystagmus and vertigo due to a solitary brachium conjunctivum plaque". J. Neurol. Neurosurg. Psychiatr. 77 (6): 790–2. doi:10.1136/jnnp.2005.084624. PMID 16705203. http://jnnp.bmj.com/cgi/pmidlookup?view=long&pmid=16705203. 

·  ^ Li N, Wang L, Cui L, et al (2008). "Five novel mutations of the FRMD7 gene in Chinese families with X-linked infantile nystagmus". Mol. Vis. 14: 733-8. PMID 18431453. 

·  ^ Dorigueto RS, Ganança MM, Ganança FF (2005). "The number of procedures required to eliminate positioning nystagmus in benign paroxysmal positional vertigo". Rev Bras Otorrinolaringol (Engl Ed) 71 (6): 769–75. PMID 16878247. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72992005000600014&lng=en&nrm=iso&tlng=en. 

·  ^ Lindgren, Stefan (1993) (in Swedish). Kliniska färdigheter: Informationsutbytet mellan patient och läkare. Lund: Studentlitteratur. ISBN 91-44-37271-X. 

·  ^ Memantine/Gabapentin for the treatment of congenital nystagmus. PMID: 17764629

·  ^ Groves, Nancy. Many options to treat nystagmus, more in development. Ophthalmology Times, March 15, 2006. [1]

·  ^ Biousse V, Tusa RJ, Russell B, et al (February 2004). "The use of contact lenses to treat visually symptomatic congenital nystagmus". J. Neurol. Neurosurg. Psychiatr. 75 (2): 314–6. PMID 14742616. http://jnnp.bmj.com/cgi/pmidlookup?view=long&pmid=14742616.

^ Cameron AJ (1933). "Marked papilloedema in pulmonary emphysema". Br J Ophthalmol 17 (3): 167–9. doi:10.1136/bjo.17.3.167. PMID 18169104.  Full text at PMC: 511527
http://en.wikipedia.org/wiki/Paraplegia

^ American Tinnitus Association | Home | Help For Ringing In The Ears
^ Dictionary of tinnitus - Merriam-Webster Online Dictionary
^ RNID.org.uk: Information and resources: Tinnitus: About tinnitus: What is tinnitus
^ MedlinePlus Encyclopedia Ear noises or buzzing
^ Holgers KM, Pettersson B (2005). "Noise exposure and subjective hearing symptoms among school children in Sweden". Noise & Health 7 (27): 27–37. PMID 16105247. http://openurl.ingenta.com/content/nlm?genre=article&issn=1463-1741&volume=7&issue=27&spage=27&aulast=Holgers. 
^ Guidelines for the Grading of Tinnitus Severity
^ Newman CW, Jacobson GP, Spitzer JB (Feb 1996). "Development of the Tinnitus Handicap Inventory". Arch Otolaryngol Head Neck Surg. 122 (2): 143–8. PMID 8630207. 
^ ENT Health Information > Hearing > Tinnitus
^ a b RNID.org.uk: Information and resources: Our factsheets and leaflets: Tinnitus: Factsheets and leaflets
^ Chandler JR (Jul 1983). "Diagnosis and cure of venous hum tinnitus". Laryngoscope 93 (7): 892–5. doi:10.1288/00005537-198307000-00009. PMID 6865626. 
^ Moonis G, Hwang CJ, Ahmed T, Weigele JB, Hurst RW (2005). "Otologic manifestations of petrous carotid aneurysms". AJNR Am J Neuroradiol. 26 (6): 1324–7. PMID 15956490. http://www.ajnr.org/cgi/pmidlookup?view=long&pmid=15956490. 
^ Selim M, Caplan LR (Jun 2004). "Carotid Artery Dissection" ([dead link] – Scholar search). Curr Treat Options Cardiovasc Med. 6 (3): 249–253. doi:10.1007/s11936-996-0020-z. PMID 15096317. http://www.treatment-options.com/1092-8464/6/249. 
^ Yamasoba T, Kondo K (Jul 2006). "Supporting cell proliferation after hair cell injury in mature guinea pig cochlea in vivo". Cell Tissue Res. 325 (1): 23–31. doi:10.1007/s00441-006-0157-9. PMID 16525832. 
^ White PM, Doetzlhofer A, Lee YS, GrovesAK, Segil N (Jun 2006). "Mammalian cochlear supporting cells can divide and trans-differentiate into hair cells". Nature 441 (7096): 984–7. doi:10.1038/nature04849. PMID 16791196. 
^ "Tinnitus cure 'is a step closer'". BBC News (news.bbc.co.uk). 2009-03-25. http://news.bbc.co.uk/2/hi/health/7959785.stm. Retrieved on 2009-03-27. 
^ IngentaConnect Drug-induced Otoxicity: Current Status
^ Brown RD, Penny JE, Henley CM, et al (1981). "Ototoxic drugs and noise". Ciba Found Symp. 85: 151–71. PMID 7035098. 
^ Crummer RW, Hassan GA (Jan 2004). "Diagnostic approach to tinnitus". Am Fam Physician. 69 (1): 120–6. PMID 14727828. 
^ Vibramycin, Vibramycin 50, Patient Information Leaflet from the eMC
^ http://www.erowid.org/library/books_online/tihkal/tihkal36.shtml,Erowid Online Books : "TIHKAL" - #36. 5-MEO-DET
^ https://www.erowid.org/experiences/exp.php?ID=26540,Erowid Experience Vaults: DiPT - More Tripping & Revelations - 26540
^ Willen SN, Einstein DB, Maciunas RJ, Megerian CA (Nov 2005). "Treatment of glomus jugulare tumors in patients with advanced age: planned limited surgical resection followed by staged gamma knife radiosurgery: a preliminary report". Otol Neurotol. 26 (6): 1229–34. doi:10.1097/01.mao.0000176170.41399.fd. PMID 16272947. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00129492-200511000-00026. 
^ De Ridder D, De Ridder L, Nowé V, Thierens H, Van de Heyning P, Møller A (Dec 2005). "Pulsatile tinnitus and the intrameatal vascular loop: why do we not hear our carotids?". Neurosurgery 57 (6): 1213–7; discussion 1213–7. PMID 16331169. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00006123-200512000-00017. 
^ Penney SE, Bruce IA, Saeed SR (Jul 2006). "Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature". J Neurology 253 (7): 857–60. doi:10.1007/s00415-006-0039-9. PMID 16845571. 
^ Albertino S, AssunçãoAR, Souza JA (2005). "Pulsatile tinnitus: treatment with clonazepam and propranolol". Braz J Otorhinolaryngol. 71 (1): 111–3. doi:/S0034-72992005000100022. PMID 16446904. 
^ hygieneexpert.co.uk Ear Care and Wax Build Up
^ Swedish website about tinnitus
^ American Hearing Research Foundation Chicago, Illinois 2008
^ Rogers, June Walker (1984). Only When I Eat: Tinnitus - Hope at Last. J.Rogers,London and Ki Publishing Richmond, Surrey. ISBN 0-9510769-0-6. 
^ Meyerhoff WL, Mickey BE (Jun 1988). "Vascular decompression of the cochlear nerve in tinnitus sufferers". Laryngoscope 98 (6 Pt 1): 602–4. doi:10.1288/00005537-198806000-00004. PMID 3374234. 
^ a b Knox GW, McPherson A (Mar 1997). "Menière's disease: differential diagnosis and treatment". Am Fam Physician. 55 (4): 1185–90, 1193–4. PMID 9092280. 
^ Pugh R, Budd RJ, Stephens SD (Oct 1995). "Patients' reports of the effect of alcohol on tinnitus". Br J Audiol. 29 (5): 279–83. doi:10.3109/03005369509076743. PMID 8838550. 
^ Arda HN, Tuncel U, Akdogan O, Ozluoglu LN (Jan 2003). "The role of zinc in the treatment of tinnitus". Otol Neurotol. 24 (1): 86–9. doi:10.1097/00129492-200301000-00018. PMID 12544035. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1531-7129&volume=24&issue=1&spage=86. 
^ Yetiser S, Tosun F, Satar B, Arslanhan M, Akcam T, Ozkaptan Y (Oct 2002). "The role of zinc in management of tinnitus". Auris, Nasus, Larynx 29 (4): 329–33. doi:10.1016/S0385-8146(02)00023-8. PMID 12393036. http://linkinghub.elsevier.com/retrieve/pii/S0385814602000238. 
^ Paaske PB, Pedersen CB, Kjems G, Sam IL (Aug 1991). "Zinc in the management of tinnitus. Placebo-controlled trial". Ann Otol Rhinol Laryngol. 100 (8): 647–9. PMID 1872515. 
^ Azevedo AA, Figueiredo RR (2005). "Tinnitus treatment with acamprosate: double-blind study". Braz J Otorhinolaryngol. 71 (5): 618–23. doi:/S0034-72992005000500012. PMID 16612523. 
^ Brookler KH, Tanyeri H (Jun 1997). "Etidronate for the the neurotologic symptoms of otosclerosis: preliminary study". Ear, nose, & throat journal 76 (6): 371–6, 379–81. PMID 9210803. 
^ Goodey RJ (1981). "Drugs in the treatment of tinnitus". Ciba Found Symp. 85: 263–78. PMID 6799263. 
^ Levine RA (2006). "Typewriter tinnitus: a carbamazepine-responsive syndrome related to auditory nerve vascular compression". ORL J Otorhinolaryngol Relat Spec. 68 (1): 43–6; discussion 46–7. doi:10.1159/000090490. PMID 16514262. 
^ Megwalu UC, Finnell JE, Piccirillo JF (Feb 2006). "The effects of melatonin on tinnitus and sleep". Otolaryngol Head Neck Surg. 134 (2): 210–3. doi:10.1016/j.otohns.2005.10.007. PMID 16455366. 
^ Zöger S, Svedlund J, Holgers KM (Feb 2006). "The effects of sertraline on severe tinnitus suffering--a randomized, double-blind, placebo-controlled study". J Clin Psychopharmacol. 26 (1): 32–9. doi:10.1097/01.jcp.0000195111.86650.19. PMID 16415703. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00004714-200602000-00008. 
^ Williams HL, Maher FT, Corbin KB, et al (Dec 1963). "Eriodictyol glycoside in the treatment of Meniere’s disease". Ann Otol Rhinol Laryngol. 72: 1082–101. PMID 14088725. 
^ Langguth B, Zowe M, Landgrebe M, et al (2006). "Transcranial magnetic stimulation for the treatment of tinnitus: a new coil positioning method and first results". Brain Topography 18 (4): 241–7. doi:10.1007/s10548-006-0002-1. PMID 16845596. 
^ Fregni F, Marcondes R, Boggio PS, et al (Sep 2006). "Transient tinnitus suppression induced by repetitive transcranial magnetic stimulation and transcranial direct current stimulation". Eur J Neurol. 13 (9): 996–1001. doi:10.1111/j.1468-1331.2006.01414.x. PMID 16930367. 
^ Aydemir G, Tezer MS, Borman P, Bodur H, Unal A (Jun 2006). "Treatment of tinnitus with transcutaneous electrical nerve stimulation improves patients' quality of life". J Laryngol Otol. 120 (6): 442–5. doi:10.1017/S0022215106000910. PMID 16556347. 
^ De Ridder D, De Mulder G, Verstraeten E, et al (2006). "Primary and secondary auditory cortex stimulation for intractable tinnitus". ORL J Otorhinolaryngol Relat Spec. 68 (1): 48–54; discussion 54–5. doi:10.1159/000090491. PMID 16514263. 
^ news.bbc.co.uk, New hope for tinnitus sufferers
^ Goto F, Ogawa K, Kunihiro T, Kurashima K, Kobayashi H, Kanzaki J (Jan 2001). "Perilymph fistula—45 case analysis". Auris, Nasus, Larynx 28 (1): 29–33. doi:10.1016/S0385-8146(00)00089-4. PMID 11137360. http://linkinghub.elsevier.com/retrieve/pii/S0385-8146(00)00089-4. 
^ Tinnitus masker - sonic designs by Jon Dattorro...
^ Filtered Noise Generator
^ Herraiz C, Hernandez FJ, Plaza G, de los Santos G (Nov 2005). "Long-term clinical trial of tinnitus retraining therapy". Otolaryngol Head Neck Surg. 133 (5): 774–9. doi:10.1016/j.otohns.2005.07.006. PMID 16274808. 
^ Henry JA, Schechter MA, Zaugg TL, et al (Feb 2006). "Outcomes of clinical trial: tinnitus masking versus tinnitus retraining therapy". J Am Acad Audiol. 17 (2): 104–32. doi:10.3766/jaaa.17.2.4. PMID 16640064. 
^ Kusatz M, Ostermann T, Aldridge D (2005). "Auditive stimulation therapy as an intervention in subacute and chronic tinnitus: a prospective observational study". Int Tinnitus J. 11 (2): 163–9. PMID 16639917. 
^ OHSU Tinnitus Clinic: Comprehensive Treatment Programs including Tinnitus Retraining Therapy (TRT)
^ Goldstein BA, Shulman A, Lenhardt ML (2005). "Ultra-high-frequency ultrasonic external acoustic stimulation for tinnitus relief: a method for patient selection". Int Tinnitus J. 11 (2): 111–4. PMID 16639909. 
^ Goldstein BA, Lenhardt ML, Shulman A (2005). "Tinnitus improvement with ultra-high-frequency vibration therapy". Int Tinnitus J. 11 (1): 14–22. PMID 16419683. 
^ Claussen CF (2005). "Subdividing tinnitus into bruits and endogenous, exogenous, and other forms". Int Tinnitus J. 11 (2): 126–36. PMID 16639912. 
^ Andersson G, Porsaeus D, Wiklund M, Kaldo V, Larsen HC (Nov 2005). "Treatment of tinnitus in the elderly: a controlled trial of cognitive behavior therapy". Int J Audiol. 44 (11): 671–5. doi:10.1080/14992020500266720. PMID 16379495. 
^ Low Level Laser Therapy for Tinnitus - Tinnitus Information Center
^ Telegraph.co.uk "Richard Attenborough: the trouper"
^ [1]
^ Beethoven: A Life of Sound and Silence - Huxtable 1 (1): 8 - Molecular Interventions
^ BBC Sports
^ a b c Perusse B (2007-12-10). "Artists sound off on hearing loss". The Gazette (Montreal). http://www.canada.com/montrealgazette/news/arts/story.html?id=e4da789c-0e37-4ed1-aafb-edb110ae247f. 
^ Disco-disco.com
^ Van Guard News Network Article
^ [2]
^ - BBC News The Doors postpone reuinion
^ 90's a symphony and 100 is loud
^ OCRegister.com - "Pop Life"
^ - Music Section - New York Times
^ Metalsludge.com: 20 Questions with Paul Gilbert. 27 April 2004
^ - Scotsman - "Gary Glitter boards flight to Hong Kong"
^ a b c d e f Wallechinsky, David; Amy Wallace (2005). The New Book of Lists. US: Canongate. pp. 161. ISBN 1841957194. http://books.google.com/books?id=tdY_N5gpOy4C. 
^ http://www.ums.org/assets/pdf/studyguide/haden-sg.pdf
^ "Japanese pop star deaf in one ear". BBC. 2008-01-07. http://news.bbc.co.uk/2/hi/entertainment/7174893.stm. Retrieved on 2008-01-08. 
^ [3]
^ "Biography for Adolf Hitler"
^ A Prairie Home Companion. The Old Scout: The Unknown Person at the Airport June 19, 2007
^ Spokane7.com
^ a b The Church, Interview 27 July 2006
^ Feldmann H (1989). "[Martin Luther's seizure disorder]" (in German). Sudhoffs Archiv 73 (1): 26–44. PMID 2529669. 
^ a b c The Independent. Health & Wellbeing. 11 December 2002. Hearing Things.
^ - Telegraph.co.uk - Joseph Mawle: Playing Jesus
^ [4]
^ AAA: Tinnitus: Noises No One Else Can Hear
^ City Pages "Mission Impossible"
^ Tinnitus: home: What is tinnitus?: Celebrities
^ Internet Movie Database. Biography for Leonard Nimoy
^ Internet Movie Database profile
^ [5]
^ "Shatner almost committed suicide over tinnitus trouble". Yahoo News UK (uk.news.yahoo.com). 2009-03-06. http://uk.news.yahoo.com/1/20090306/ten-shatner-almost-committed-suicide-ove-c60bd6d.html. Retrieved on 2009-03-27. 
^ Cleveland State University - Czech Garden
^ - Telegraph.co.uk - How he went to the dogs
^ Action for Tinnitus Research
^ British Tinnitus Association
^ Reader's Digest. Healthier Living. Tinnitus: Terror in Your Ear. Francine Fiore and Anne Paillard
·  ^ "Definition of vertigo". Merriam-Webster Online Dictionary. http://www.m-w.com/dictionary/vertigo. Retrieved on 2007-09-19. 

·  ^ "Core Curriculum: Inner Ear Disease - Vertigo". BaylorCollege of Medicine. 2006-01-23. http://www.bcm.edu/oto/studs/vertigo.html. Retrieved on 2007-09-19.

^ Jay WM (1981). "Visual field defects". American family physician 24 (2): 138–42. PMID 7258077. 
A family of misunderstood disorders, by Richard N Fogoros
 

^ Andrew Gilies, A brief history of the basal ganglia, retrieved on 27 June 2005
^ Alm PA (2004). "Stuttering and the basal ganglia circuits: a critical review of possible relations". Journal of communication disorders 37 (4): 325–69. doi:10.1016/j.jcomdis.2004.03.001. PMID 15159193. http://theses.lub.lu.se/scripta-archive/2005/02/02/med_1035/part2/Per_Alm_Paper_II.pdf. 
^ Soltanzadeh, Akbar (2004). Neurologic Disorers. Tehran: Jafari. ISBN 964-6088-03-1. 
Nolte, John, The Human Brain: An Introduction to its Functional Anatomy (Fifth Edition). (St. Louis: Mosby, Inc., 2002), 464-484. ISBN 0-323-01320-1
Parent, André, Comparative Neurobiology of the Basal Ganglia (Wiley, New York, 1986), ISBN 0-471-80348-0
Reynolds JN, Hyland BI, Wickens JR (2001). "A cellular mechanism of reward-related learning". Nature 413 (6851): 67–70. doi:10.1038/35092560. PMID 11544526.
^ Rakheja D, Narayan SB, Bennett MJ (September 2007). "Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update". Curr. Mol. Med. 7 (6): 603–8. doi:10.2174/156652407781695729. PMID 17896996. http://www.bentham-direct.org/pages/content.php?CMM/2007/00000007/00000006/0007M.SGM. 
^ synd/7 at Who Named It?
^ F. E. Batten. Cerebral degeneration with symmetrical changes in the maculae in two members of a family. Transactions of the Ophthalmological Societies of the United Kingdom, 1902, 23: 386-390.
^ "Clinical Trial: Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis". http://www.clinicaltrials.gov/ct/show/NCT00151216. Retrieved on 2007-06-08. 
^ "A stem cell first at OHSU" The Portland Tribune, Nov 24, 2006
^ "[1]Child who received stem cells from aborted fetus on way home"
^ a b Greenlee RT, Murray T, Bolden S, Wingo PA (2000). "Cancer statistics, 2000". CA Cancer J Clin 50 (1): 7–33. doi:10.3322/canjclin.50.1.7. PMID 10735013. http://caonline.amcancersoc.org/cgi/reprint/50/1/7. 
^ a b American Cancer Society. Accessed June 2000.
^ Chamberlain MC, Kormanik PA (Feb 1998). "Practical guidelines for the treatment of malignant gliomas". West J Med. 168 (2): 114–20. PMID 9499745. 
^ Gurney, James G; Smith, Malcolm A; Bunin, Greta R. "CNS and Miscellaneous Intracranial and Instraspinal Neoplasms" (PDF). SEER Pediatric Monograph. National Cancer Institute. pp. 51–52 (incidence); pp. 56–57 (trends); p. 57 (survival). http://seer.cancer.gov/publications/childhood/cns.pdf. Retrieved on 4 December 2008. "[re incidence] In the US, approximately 2,200 children and adolescents younger than 20 years of age are diagnosed with malignant central nervous system tumors each year. Over 90 percent of primary CNS malignancies in children are located within the brain." 
^ Infantile Brain Tumors by Brian Rood for The Childhood Brain Tumor Foundation (accessed July 2007)
^ Echevarría ME, Fangusaro J, Goldman S (June 2008). "Pediatric central nervous system germ cell tumors: a review". Oncologist 13 (6): 690–9. doi:10.1634/theoncologist.2008-0037. PMID 18586924. 
^ Radiosurgery treatment comparisons - Cyberknife, Gamma knife, Novalis Tx
^ Nakamura M, Konishi N, Tsunoda S, et al (Feb 2000). "Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults". Oncology 58 (2): 108–16. doi:10.1159/000012087. PMID 10705237. http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=ocl58108. 
^ Clinical trials in brain tumors.. Accessed June 2000.
^ Nicolato A, Gerosa MA, Fina P, Iuzzolino P, Giorgiutti F, Bricolo A (Sep 1995). "Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients". Surg Neurol 44 (3): 208–21; discussion 221–3. doi:10.1016/0090-3019(95)00184-0. PMID 8545771. http://linkinghub.elsevier.com/retrieve/pii/0090-3019(95)00184-0. 
^ Janny P, Cure H, Mohr M, et al (Apr 1994). "Low grade supratentorial astrocytomas. Management and prognostic factors". Cancer 73 (7): 1937–45. doi:10.1002/1097-0142(19940401)73:7<1937::AID-CNCR2820730727>3.0.CO;2-G. PMID 8137221. 
^ Piepmeier J, Christopher S, Spencer D, et al (May 1996). "Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas". Neurosurgery 38 (5): 872–8; discussion 878–9. doi:10.1097/00006123-199605000-00002. PMID 8727811. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0148-396X&volume=38&issue=5&spage=872. 
^ Treating secondary brain tumours with WBRT
^ Whole Brain Radiation increases risk of learning and memory problems in cancer patients with brain metastases
^ IRSA - International RadioSurgery Association - Metastatic brain tumors
^ Researchers Find Cancer-Killing Virus; July 24, 2000.
^ Yale Lab Engineers Virus That Can Kill Deadly Brain Tumors; February 21, 2008.
^ "Cerebral Palsy." (National Center on Birth Defects and Developmental Disabilities, October 3, 2002), www.cdc.gov
^ a b c d e Beukelman, David R.; Mirenda (1999). Augmentative and Alternative Communication: Management of severe communication disorders in children and adults. Pat (2 ed.). Baltimore: Paul H Brookes Publishing Co. pp. 246–249. 
^ "Cerebral Palsy - Topic Overview". http://children.webmd.com/tc/cerebral-palsy-topic-overview. Retrieved on 2008-02-06. 
^ WebMD Medical Reference from Healthwise. 
^ Anonymus (2007). "Definition and classification of cerebral palsy, Feb 2007". Developmental medicine and child neurology 49 (8): 8. 
^ "Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment—United States, 2003". MMWR Morb. Mortal. Wkly. Rep. 53 (3): 57–9. 2004. PMID 14749614. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5303a4.htm. Retrieved on 2007-08-12. 
^ "Summary of "The Epidemiology of cerebral palsy: incidence, impairments and risk factors"". United Cerebral Palsy Research and Education Foundation (U.S.). http://www.ucpresearch.org/fact-sheets/epidemiology-cerebral-palsy.php. Retrieved on 5 July 2007. 
^ "Information: Scope". http://www.scope.org.uk/information/cp.shtml. Retrieved on 2007-12-08. 
^ Groch, Judith (January 5). "Medical News: Cerebral Palsy Rates Decline in Very Low Birthweight Children - in Neurology, General Neurology from MedPage Today". MedPage Today. http://www.medpagetoday.com/Neurology/GeneralNeurology/tb2/4812. Retrieved on 2007-12-08. 
^ Birol Balaban, Evren Yasar, Ugur Dal, Kamil Yazicioglu, Haydar Mohur & Tunc Alp Kalyon "The effect of hinged ankle-foot orthosis on gait and energy expenditure in spastic hemiplegic cerebral palsy" Disability and Rehabilitation, January 2007; 29(2): 139–144
^ "Thames Valley Children's Centre - Cerebral Palsy - Causes and Prevalence". http://www.tvcc.on.ca/gateway.php?id=167&cid=2. Retrieved on 2007-06-11. 
^ a b Johnson, Ann (2002). "Prevalence and characteristics of children with cerebral palsy in Europe". Developmental medicine and child neurology 44 (9): 633–40. doi:10.1017/S0012162201002675. PMID 12227618. http://journals.cambridge.org/production/action/cjoGetFulltext?fulltextid=120612. 
^ United Cerebral Palsy Research and Education Foundation (U.S.). "Cerebral Palsy Fact Sheet" (PDF). http://www.ucp.org/uploads/cp_fact_sheet.pdf. Retrieved on 12 August 2007. 
^ Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007). "How common are the "common" neurologic disorders?". Neurology 68 (5): 326–37. doi:10.1212/01.wnl.0000252807.38124.a3. PMID 17261678. 
^ Thorngren-Jerneck K, Herbst A (2006). "Perinatal factors associated with cerebral palsy in children born in Sweden". Obstetrics and gynecology 108 (6): 1499–505. doi:10.1097/01.AOG.0000247174.27979.6b (inactive 2008-06-25). PMID 17138786. 
^ Childhood dysarthria: Notes from Childhood Motor Speech Disability by Love
^ "Cerebral Palsy - Facts & Figures: History". United Cerebral Palsy Research and Education Foundation (U.S.). http://www.ucp.org/ucp_generaldoc.cfm/1/9/37/37-37/447#history. Retrieved on 2007-07-06. 
^ "Cerebral Palsy: Hope Through Research". National Institute of Neurological Disorders and Stroke (U.S.). NIH Publication No. 06-159. July 2006. http://www.ninds.nih.gov/disorders/cerebral_palsy/detail_cerebral_palsy.htm#88033104. Retrieved on 2007-07-06. 
^ Pharoah PO (November 2007). "Prevalence and pathogenesis of congenital anomalies in cerebral palsy". Arch. Dis. Child. Fetal Neonatal Ed. 92 (6): F489–93. doi:10.1136/adc.2006.107375. PMID 17428819. 
^ Pharoah PO (December 2005). "Causal hypothesis for some congenital anomalies". Twin Res Hum Genet 8 (6): 543–50. doi:10.1375/183242705774860141. PMID 16354495. 
^ Pharoah PO (June 2006). "Risk of cerebral palsy in multiple pregnancies". Clin Perinatol 33 (2): 301–13. doi:10.1016/j.clp.2006.03.017. PMID 16765726. 
^ "Infection in the Newborn as a Cause of Cerebral Palsy, 12/2004". United Cerebral Palsy Research and Education Foundation (U.S.). http://www.ucpresearch.org/fact-sheets/infection-newborn.php. Retrieved on 2007-07-05. 
^ Kolawole TM, Patel PJ, Mahdi AH (1989). "Computed tomographic (CT) scans in cerebral palsy (CP)". Pediatr Radiol 20 (1–2): 23–7. doi:10.1007/BF02010628. PMID 2602010. 
^ Ashwal S, Russman BS, Blasco PA, et al (2004). "Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the AmericanAcademy of Neurology and the Practice Committee of the Child Neurology Society". Neurology 62 (6): 851–63. PMID 15037681. 
^ Jenks KM, de Moor J, van Lieshout EC, Maathuis KG, Keus I, Gorter JW (2007). "The effect of cerebral palsy on arithmetic accuracy is mediated by working memory, intelligence, early numeracy, and instruction time". Dev Neuropsychol 32 (3): 861–79. doi:10.1080/87565640701539758 (inactive 2009-04-04). PMID 17956186. 
^ Strauss D, Brooks J, Rosenbloom R, Shavelle R (2008). "Life Expectancy in cerebral palsy: an update". Developmental Medicine & Child Neurology 50: 487–93. 
^ Online 'Mendelian Inheritance in Man' (OMIM) CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE -603513
^ Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, Poole WK (2006). "Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants". Pediatrics 117 (4): 1253–61. doi:10.1542/peds.2005-1368. PMID 16585322. 
^ Hansen, Ruth A.; Atchison, Ben (2000). Conditions in occupational therapy: effect on occupational performance. Hagerstown, MD: Lippincott Williams & Wilkins. ISBN 0-683-30417-8. 
^ Crepeau, Elizabeth Blesedell; Willard, Helen S.; Spackman, Clare S.; Neistadt, Maureen E. (1998). Willard and Spackman's occupational therapy. Philadelphia: Lippincott-Raven Publishers. ISBN 0-397-55192-4. 
^ Balaban B, Yasar E, Dal U, Yazicioglu K, Mohur H, Kalyon TA (2007). "The effect of hinged ankle-foot orthosis on gait and energy expenditure in spastic hemiplegic cerebral palsy". Disability and rehabilitation 29 (2): 139–44. PMID 17373095. 
^ White H, Jenkins J, Neace WP, Tylkowski C, Walker J (2002). "Clinically prescribed orthoses demonstrate an increase in velocity of gait in children with cerebral palsy: a retrospective study". Developmental medicine and child neurology 44 (4): 227–32. doi:10.1017/S0012162201001992. PMID 11995890. 
^ Pennington L, Goldbart J, Marshall J (2004). "Speech and language therapy to improve the communication skills of children with cerebral palsy". Cochrane database of systematic reviews (Online) (2): CD003466. doi:10.1002/14651858.CD003466.pub2. PMID 15106204. 
^ McDonagh MS, Morgan D, Carson S, Russman BS (2007). "Systematic review of hyperbaric oxygen therapy for cerebral palsy: the state of the evidence". Dev Med Child Neurol 49 (12): 942–7. doi:10.1111/j.1469-8749.2007.00942.x. PMID 18039243. 
^ Macgregor R, Campbell R, Gladden MH, Tennant N, Young D (2007). "Effects of massage on the mechanical behaviour of muscles in adolescents with spastic diplegia: a pilot study". Developmental medicine and child neurology 49 (3): 187–91. doi:10.1111/j.1469-8749.2007.00187.x (inactive 2008-06-25). PMID 17355474. 
^ Schejbalová A (2006). "[Derotational subtrochanteric osteotomy of the femur in cerebral palsy patients]" (in Czech). Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca 73 (5): 334–9. PMID 17140515. 
^ Farmer JP, Sabbagh AJ (2007). "Selective dorsal rhizotomies in the treatment of spasticity related to cerebral palsy". Child s Nervous System 23: 991. doi:10.1007/s00381-007-0398-2. PMID 17643249. 
^ Hawamdeh ZM, Ibrahim AI, Al-Qudah AA (2007). Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy. PMID 17268388. 
^ Shankaran S, LaptookAR, Ehrenkranz RA, et al (2005). "Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy". N. Engl. J. Med. 353 (15): 1574–84. doi:10.1056/NEJMcps050929. PMID 16221780. 
^ "Amazing recovery attributed to cord blood - Health - MSNBC.com". http://today.msnbc.msn.com/id/23572206/. Retrieved on 2008-03-28. 
^ AmericanAcademy of Pediatrics. Committee on Children with Disabilities (1999). "The treatment of neurologically impaired children using patterning". Pediatrics 104 (5): 1149–51. doi:10.1542/peds.104.5.1149. PMID 10545565. http://pediatrics.aappublications.org/cgi/content/full/104/5/1149. 
^ Pauling, Linus (November 1978). "Orthomolecular enhancement of human development". Human Neurological Development: Past, Present, and Future. A Joint Symposium Sponsored by NASA/Ames Research Center and the Institutes for the Achievement of Human Potential. NASA CP 2063: 47–51.
^ David Melton, Todd: The Story of a Brain-Injured Child, Philadelphia: The Better Baby Press, 1985.
^ Berg, Kevin (January 2005). "chapter 3: patterning", A Life with Purpose. Kevin Berg Books, 80. ISBN 1-4116-2252-9.
^ Leone Nunley with Dean Merrill, Fighting for David. Carol, Illinois: Tyndale House Publishers, Inc., 2006
^ Access Economics (2008) The Economic Impact of Cerebral Palsy in Australia in 2007. Access Economics, Canberra, ACT.
^ "Cerebral Palsy: a Guide for Care". http://gait.aidi.udel.edu/res695/homepage/pd_ortho/clinics/c_palsy/cpweb.htm. Retrieved on 2007-07-29. 
^ a b "A very telling tale". http://society.guardian.co.uk/charitymanagement/story/0,8150,719600,00.html. Retrieved on 2007-07-29. 
^ Zimmer, Benjamin (2007-02-05). "A brief history of "spaz"" (HTML). Language Log. University of Pennsylvania. http://itre.cis.upenn.edu/~myl/languagelog/archives/003020.html. Retrieved on 2007-07-29. 
^ snowdrop.cc
^ "The Sheila Variations: August 2, 1776: "My hand trembles, but my heart does not"". http://www.sheilaomalley.com/archives/000942.html. Retrieved on 2007-07-29. 
^ "About Marie Killilea". http://www.parsley.org/killilea/about.html. Retrieved on 2007-07-29. 
^ Pearce JM (2000). "The emperor with the shaking head". Journal of the Royal Society of Medicine 93 (6): 335–6. PMID 10911840. 
^ Death of Irish author Christopher Nolan announced, The Irish Times, 20 February 2009, retrieved 20 February 2009
·  ^ a b c Fine EJ, Ionita CC, Lohr L (2002). "The history of the development of the cerebellar examination". Semin Neurol 22 (4): 375–84. doi:10.1055/s-2002-36759. PMID 12539058. 

·  ^ Rapp, Brenda (2001). The Handbook of Cognitive Neuropsychology: What Deficits Reveal about the Human Mind. Psychology Press. pp. 481. ISBN 1841690449. 

·  ^ The Brain From Top To Bottom

·  ^ Muller F, O'Rahilly R (1990). "The human brain at stages 21–23, with particular reference to the cerebral cortical plate and to the development of the cerebellum". Anat Embryol (Berl) 182 (4): 375–400. doi:10.1007/BF02433497. PMID 2252222. 

·  ^ Hunter B. Fraser, Philipp Khaitovich, Joshua B. Plotkin, Svante Paabo & Michael B. Eisen (September 2005). "Aging and gene expression in the primate brain". PLoS Biology 3 (9): e274. doi:10.1371/journal.pbio.0030274. PMID 16048372. http://biology.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pbio.0030274. 

Faculty of Arts and Sciences, HarvardUniversity (2005-08-01). Human Cerebellum And Cortex Age In Very Different Ways. Press release. http://www.fas.harvard.edu/home/news_and_events/releases/age_08012005.html. Retrieved on 2008-08-25. 
·  ^ Birgitte Bo Andersen, Hans Jørgen G. Gundersen, Bente Pakkenberg (2003). "Aging of the human cerebellum: A stereological study". The Journal of Comparative Neurology 466 (3): 356–365. doi:10.1002/cne.10884. 

·  ^ Naftali Raz, Faith Gunning-Dixon, Denise Head, Adrienne Williamson & James D. Acker (June/July 2001). "Age and Sex Differences in the Cerebellum and the Ventral Pons: A Prospective MR Study of Healty Adults" (PDF). American Journal of Neuroradiology 22: 1161–1167. http://www.ajnr.org/cgi/reprint/22/6/1161.pdf. 

·  ^ Sharon L. Eastwood, Philip W. J. Burnet, Rebecca Gittins, Kate Baker, Paul J. Harrison (November 2001). "Expression of 5-HT2A receptors in the human cerebellum and alterations in schizophrenia". Synapse 42 (2): 104–114. doi:10.1002/syn.1106. 

·  ^ K. H. Adams, Lars H. Pinborg, Claus Svarer, S. G. Hasselbalch, Søren Holm, S. Haugbøl, K. Madsen, Vibe G. Frøkjaer, L. Martiny, Olaf B. Paulson, Gitte Moos Knudsen (March 2004). "A database of [18F]-altanserin binding to 5-HT2A receptors in normal volunteers: normative data and relationship to physiological and demographic variables". NeuroImage 21 (3): 1105–1113. doi:10.1016/j.neuroimage.2003.10.046. PMID 15006678. 

·  ^ Kingsley, R. E. (2000). Concise Text of Neuroscience (2nd edition ed.). Lippincott Williams and Wilkins. ISBN 0-683-30460-7. 

·  ^ John K. Harting, Ph.D. The Global Cerebellum '97,[1] University of Wisconsin Medical School.

·  ^ Kinney GA, Overstreet LS, Slater NT. Prolonged physiological entrapment of glutamate in the synaptic cleft of cerebellar unipolar brush cells. J Neurophysiol. 1997 Sep;78(3):1320-33.,

·  ^ Ramon y Cajal. R. (1904). "La Textura del Sistema Nervioso del Hombre y los Vertebrados". Madrid: Moya.

·  ^ Eccles J.C Ito, M and Szentagothai J. (1967). "The cerebellum as a neuronal machine". Springer Verlag

·  ^ Marr, D. (1969). "A theory of cerebellar cortex". J. Physiol. Lond. 202: 437-70.

·  ^ Albus, J. (1970). "A theory of cerebellar function". Math. Biosci. 10: 25-61.

·  ^ Llinás, R., Baker, R. and Sotelo, C. (1974). "Electrotonic coupling between neurons in cat inferior olive". J. Neurophysiol 37: 560-571.

·  ^ Sugihara, I., Lang, E.J. and Llinás, R. (1993). "Uniform olivocerebellar conduction time underlies Purkinje cell complex spike synchronicity in the rat cerebellum". J. Physiol. Lond. 470: 243-271.

·  ^ Welsh, J.P., Lang, E.J., Sugihara, I. and Llinás, R. (1995). "Dynamic organization of motor control within the olivocerebellar system". Nature 374: 453-457

·  ^ Lang, E.J. (2001). "Organization of olivocerebellar activity in the absence of excitatory glutamatergic input". J. Neurosci. 21: 1663-1675

·  ^ Ito, M., Yoshida, M. and Obata, K. (1964). "Monosynaptic inhibition of the intracerebellar nuclei induced from the cerebellar cortex". Experientia 20: 575-576.

·  ^ Llinas R. (1991). "The noncontinuous nature of movement execution". In: Motor Control: Concepts and Issues, eds. D.R. Humphrey and H.J. Freund, John Wiley & Sons Ltd., Dahlem Konferenzen pp 223-242.

·  ^ Ivry RB, Keele SW, Diener HC (1988). "Dissociation of the lateral and medial cerebellum in movement timing and movement execution". Exp Brain Res 73 (1): 167–80. doi:10.1007/BF00279670. PMID 3208855. 

·  ^ Pellionisz, A., Llinás, R. (1980). "Tensorial Approach To The Geometry Of Brain Function: Cerebellar Coordination Via A Metric Tensor". Neuroscience 5: 1125—-1136. doi:10.1016/0306-4522(80)90191-8. http://usa-siliconvalley.com/inst/pellionisz/80_metric/80_metric.html. 

·  ^ Pellionisz, A., Llinás, R. (1985). "Tensor Network Theory Of The Metaorganization Of Functional Geometries In The Central Nervous System". Neuroscience 16 (2): 245–273. doi:10.1016/0306-4522(85)90001-6. http://usa-siliconvalley.com/inst/pellionisz/85_metaorganization/85_metaorganization.html. 

·  ^ Boyden ES, Katoh A, Raymond JL (2004). "Cerebellum-dependent learning: the role of multiple plasticity mechanisms". Annu Rev Neurosci 27: 581–609. doi:10.1146/annurev.neuro.27.070203.144238. PMID 15217344. 

·  ^ Pellionisz A, Llinas R (1982). "Space-time representation in the brain. the cerebellum as a predictive space-time metric tensor". Neuroscience 7 (12): 2949–70. doi:10.1016/0306-4522(82)90224-X. PMID 7162624. 

·  ^ Gielen CC, van Zuylen EJ (1986). "Coordination of arm muscles during flexion and supination: application of the tensor analysis approach". Neuroscience 17 (3): 527–39. doi:10.1016/0306-4522(86)90028-X. PMID 3703248. 

·  ^ Gilman S (1998). "Imaging the brain. Second of two parts". N. Engl. J. Med. 338 (13): 889–96. PMID 9516225. 

·  ^ Obayashi S (2004). "Possible mechanism for transfer of motor skill learning: implication of the cerebellum". Cerebellum 3 (4): 204–11. doi:10.1080/14734220410018977. PMID 15686098. 

·  ^ Kim SG, Ugurbil K, Strick PL (1994). "Activation of a cerebellar output nucleus during cognitive processing". Science 265 (5174): 949–51. doi:10.1126/science.8052851. PMID 8052851. 

·  ^ Pellionisz, A (1986). "David Marr's Theory of the Cerebellar Cortex: A Model in Brain Theory for the 'Galilean Combination of Simplification, Unification and Mathematization'". in Palm G., & Aertsen, A.. Brain Theory. Springer Verlag. pp. 253–257. 

·  ^ Dr Evor L. Hines. "Intelligent Systems Engineering - Major Characteristics of Expert Systems and Artificial Neural Networks". Intelligent Systems Engineering (ES3770) Lecture Notes. http://www.eng.warwick.ac.uk/eng/staff/elh/ise/session06/ise0629.html. Retrieved on 2006-03-28. 

·  ^ "SpikeFORCE: Real-time Spiking Networks for Robot Control" (PDF). http://www.neuro-it.net/Activities/Alicante2003/spikeforce. Retrieved on 2006-03-28. 

·  ^ Pellionisz, András J.. "Tensor Network Theory of the Central Nervous System". in George Adelman. Encyclopedia of Neuroscience (II ed.). Birkhauser. pp. 1196–1198.

^ Page 117 in: Henry S. Schutta; Lechtenberg, Richard (1998). Neurology practice guidelines. New York: M. Dekker. ISBN 0-8247-0104-6. 
Thomas, Clayton L. (1985). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, Pennsylvania. ISBN 0-8036-8309-X.
Baron, M.E. (2007) Cervical Spondylosis: Diagnosis and Management. http://www.emedicine.com/neuro/topic564.htm
http://en.wikipedia.org/wiki/Central_nervous_system_infection

^ a b Krajewski KM, Lewis RA, Fuerst DR, et al (2000). "Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A". Brain 123 ( Pt 7): 1516–27. doi:10.1093/brain/123.7.1516. PMID 10869062. http://brain.oxfordjournals.org/cgi/content/full/123/7/1516#SEC4. 
^ Baloh RH, Schmidt RE, Pestronk A, Milbrandt J (2007). "Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations". J. Neurosci. 27 (2): 422–30. doi:10.1523/JNEUROSCI.4798-06.2007. PMID 17215403. http://www.jneurosci.org/cgi/content/abstract/27/2/422. 
^ a b c Berger P, Young P, Suter U (2002). "Molecular cell biology of Charcot-Marie-Tooth disease". Neurogenetics 4 (1): 1–15. doi:10.1007/s10048-002-0130-z. PMID 12030326. http://link.springer.de/link/service/journals/10048/bibs/2004001/20040001.htm. 
^ Latour P, Fabreguette A, Ressot C, et al (1997). "New mutations in the X-linked form of Charcot-Marie-Tooth disease". Eur. Neurol. 37 (1): 38–42. doi:10.1159/000117403. PMID 9018031. 
^ Andrew L Harris and Darren Locke (2009). Connexins, A Guide. New York: Springer. pp. 574. ISBN 978-1-934115-46-6. http://www.springer.com/978-1-934115-46-6. 
^ Brewer M, Changi F, Antonellis A, et al (July 2008). "Evidence of a founder haplotype refines the X-linked Charcot-Marie-Tooth (CMTX3) locus to a 2.5 Mb region". Neurogenetics 9 (3): 191–5. doi:10.1007/s10048-008-0126-4. PMID 18458969. 
^ Passage E, Norreel JC, Noack-Fraissignes P, et al (2004). "Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease". Nat. Med. 10 (4): 396–401. doi:10.1038/nm1023. PMID 15034573. 
^ "Clinical Trials - Neuromuscular Trial/Study". 2007-07-18. http://www.mda.org/research/view_ctrial.aspx?id=186. Retrieved on 2008-05-28. 
^ CMT Association: Medical Alert
·  ^ Sundsten, John W.; Nolte, John (2001). The human brain: an introduction to its functional anatomy. St. Louis: Mosby. ISBN 0-323-01320-1. 

·  ^ According to the Guinness Book of Records, the longest period spent in coma was by Elaine Esposito. She did not wake up after being anaesthetized for an appendectomy on August 6, 1941, at age 6. She died on November 25, 1978 at age 43 years 357 days, having been in a coma for 37 years 111 days.

·  ^ Formisano R, CarlesimoGA, Sabbadini M, et al (May 2004). "Clinical predictors and neuropsychological outcome in severe traumatic brain injury patients". Acta Neurochir (Wien) 146 (5): 457–62. doi:10.1007/s00701-004-0225-4. PMID 15118882. 

·  ^ brain injury .com | Coma traumatic brain injury - Brain Injury Coma

·  ^ Mother stunned by coma victim's unexpected words - smh.com.au

·  ^ "Electrodes stir man from six-year coma-like state". Cosmos Magazine. 2 August 2007. http://www.cosmosmagazine.com/node/1513.

^ American Family Physician, March 1, 2003 Delirium
^ Teng E L, Chui H C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314–18. PMID 3611032
^ Teng E L, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45–58. PMID 8054493
^ Royall, D.; Cordes J.; & Polk M. (1998). "CLOX: an executive clock drawing task". J Neurol Neurosurg Psychiatry 64 (5): 588–94. doi:10.1136/jnnp.64.5.588. PMID 9598672. http://jnnp.bmj.com/cgi/content/full/64/5/588. 
^ Boustani, M.; Peterson, B.; Hanson, L.; Harris, R.; & Lohr, K. (03 Jun 2003). "Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force". Ann Intern Med 138 (11): 927–37. PMID 12779304. http://www.annals.org/cgi/content/full/138/11/927. 
^ "Appendix: The Modified Mini-Mental State (3MS)". http://www.cjns.org/27febtoc/predicting_appendix_.html. Retrieved on 2007-09-06. 
^ a b Cullen B, O'Neill B, Evans JJ, Coen RF, Lawlor BA. A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):790-9. Epub 2006 Dec 18. PMID 17178826
^ Sager, M.; Hermann, B.; La Rue, A.; & Woodard, J. (2006). "Screening for dementia in community-based memory clinics". WMJ 105 (7): 25–9. PMID 17163083. 
^ Fleisher, A.; Sowell B.; Taylor C.; Gamst A.; Petersen R.; & Thal L. (2007). "Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment". Neurology 68: 1588. doi:10.1212/01.wnl.0000258542.58725.4c. PMID 17287448. 
^ Karlawish, J. & Clark, C. (2003). "Diagnostic evaluation of elderly patients with mild memory problems". Ann Intern Med 138 (5): 411–9. PMID 12614094. http://www.annals.org/cgi/content/full/138/5/411. 
^ Jorm, A.F. (2004). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): A review. International Psychogeriatrics, 16, 1-19.
^ Bonte, FJ; Harris TS, Hynan LS, Bigio EH, White CL 3rd (July 2006). "Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation". Clinical Nuclear Medicine 31 (7): 376–8. doi:10.1097/01.rlu.0000222736.81365.63. PMID 16785801. 
^ Dougall, NJ; Bruggink S, Ebmeier KP (Nov-December 2004). "Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia". The American Journal of Geriatric Psychiatry 12 (6): 554–70. doi:10.1176/appi.ajgp.12.6.554. PMID 15545324. 
^ "Bilingualism Has Protective Effect In Delaying Onset Of Dementia By Four Years, Canadian Study Shows". Medical News Today. 2007-01-11. http://www.medicalnewstoday.com/medicalnews.php?newsid=60646. Retrieved on 2007-01-16. 
^ Aldridge, David, Music Therapy in Dementia Care, London : Jessica Kingsley Publishers, November 2000. ISBN 1853027766
^ Tuet, R.W.K.; Lam, L.C.W. (September 2006) "A preliminary study of the effects of music therapy on agitation in Chinese patients with dementia", Hong Kong Journal of Psychiatry, Volume 16, Number 3
^ Watanabe, Tomoyuki; et al., "Effects of music therapy for dementia: A systematic review", (in Japanese) Aichi University of Education Research Reports, v.55, pp. 57-61, March, 2005
^ Koger, Susan M.; Chapin Kathyn; Brotons, Melissa, "Is Music Therapy an Effective Intervention for Dementia? : A Meta-Analytic Review of Literature", Journal of Music Therapy 36(1), February 1999, pp.2-15.
^ Remington, Ruth, "Calming Music and Hand Massage With Agitated Elderly", Nursing Research 51(5): 317-323, September/October 2002.
^ Lleo A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer's disease. Annu Rev Med. 2006;57:513-33. Review. PMID 16409164
^ Choi, Y., Kim, H.S., Shin, K.Y., Kim, E.M., Kim, M., Kim, H.S., Park, C.H., Jeong, Y.H., Yoo, J., Lee, J.P., Chang K.A., Kim S., & Suh, Y.H. Related Minocycline Attenuates Neuronal Cell Death and Improves Cognitive Impairment in Alzheimer's Disease Models. Neuropsychopharmacology. 2007 Apr 4; PMID 17406652
^ "FDA MedWatch - 2008 Safety Alerts for Human Medical Products". FDA. http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antipsychotics. 
^ "FDA MedWatch - 2008 Safety Alerts for Human Medical Products". FDA. http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antipsychotics. 
^ Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT, Mittleman MA, Siscovick DS (March 2003). "Prospective study of alcohol consumption and risk of dementia in older adults". JAMA 289 (11): 1405–13. doi:10.1001/jama.289.11.1405. PMID 12636463. 
^ Ganguli M, Vander Bilt J, Saxton JA, Shen C, Dodge HH (October 2005). "Alcohol consumption and cognitive function in late life: a longitudinal community study". Neurology 65 (8): 1210–7. doi:10.1212/01.wnl.0000180520.35181.24. PMID 16247047. 
^ Huang W, Qiu C, Winblad B, Fratiglioni L (October 2002). "Alcohol consumption and incidence of dementia in a community sample aged 75 years and older". J Clin Epidemiol 55 (10): 959–64. doi:10.1016/S0895-4356(02)00462-6. PMID 12464371. 
^ Sofi F, Cesari F, Abbate R, Gensini GF, Casini A (2008). "Adherence to Mediterranean diet and health status: meta-analysis". BMJ 337: a1344. doi:10.1136/bmj.a1344. PMID 18786971. 
^ Fillit H, Nash DT, Rundek T, Zuckerman A (June 2008). "Cardiovascular risk factors and dementia". Am J Geriatr Pharmacother 6 (2): 100–18. doi:10.1016/j.amjopharm.2008.06.004. PMID 18675769. 
^ Peters R, Beckett N, Forette F, et al (August 2008). "Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial". Lancet Neurol 7 (8): 683–9. doi:10.1016/S1474-4422(08)70143-1. PMID 18614402. 
^ Drivers with dementia a growing problem, MDs warn, CBC News, Canada, September 19, 2007
^ demyelinating disease at Dorland's Medical Dictionary
^ Commission on Epidemiology and Prognosis, International League Against Epilepsy (1993). "Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy". Epilepsia 34 (4): 592–6. doi:10.1111/j.1528-1157.1993.tb00433.x. PMID 8330566. http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1528-1157.1993.tb00433.x. 
^ Blume W, Lüders H, Mizrahi E, Tassinari C, van Emde Boas W, Engel J (2001). "Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology". Epilepsia 42 (9): 1212–8. doi:10.1046/j.1528-1157.2001.22001.x. PMID 11580774. http://www.blackwell-synergy.com/doi/full/10.1046/j.1528-1157.2001.22001.x. 
^ Fisher R, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J (2005). "Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)". Epilepsia 46 (4): 470–2. doi:10.1111/j.0013-9580.2005.66104.x. PMID 15816939. http://www.blackwell-synergy.com/doi/full/10.1111/j.0013-9580.2005.66104.x. 
^ "Epilepsy: aetiogy [sic], epidemiology and prognosis". World Health Organization. February 2001. http://www.who.int/mediacentre/factsheets/fs165/en/. Retrieved on 2007-06-14. 
^ The National Society for Epilepsy (2009), What is Epilepsy?. Available from http://www.epilepsynse.org.uk/AboutEpilepsy/Whatisepilepsy (Accessed on 15 February 2009).
^ Cascino GD (1994). "Epilepsy: contemporary perspectives on evaluation and treatment". Mayo Clinic Proc 69: 1199–1211. 
^ Engel J Jr (1996). "Surgery for seizures". NEJM 334: 647–652. doi:10.1056/NEJM199603073341008. PMID 8592530. 
^ "Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy". Epilepsia 22 (4): 489–501. 1981. doi:10.1111/j.1528-1157.1981.tb06159.x. PMID 6790275. 
^ a b "Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy". Epilepsia 30 (4): 389–99. 1989. doi:10.1111/j.1528-1157.1989.tb05316.x. PMID 2502382. 
^ Jerome Engel. "A Proposed Diagnostic Scheme For People With Epileptic Seizures And With Epilepsy: Report Of The Ilae Task Force On Classification And Terminology". ILAE. http://www.ilae-epilepsy.org/Visitors/Centre/ctf/overview.cfm. Retrieved on 2006-07-18. 
^ Frucht MM, Quigg M, Schwaner C, FountainNB. (2000). "Distribution of seizure precipitants among epilepsy syndromes.". Epilepsia 41 (12): 1534–1539.. doi:10.1111/j.1499-1654.2000.001534.x. 
^ Herzog AG, Harden CL, Liporace J, Pennell P, Schomer DL, Sperling M, et al. (2004). "Frequency of catamenial seizure exacerbation in women with localization-related epilepsy". Annals Neurology 56 (3): 431–34. doi:10.1002/ana.20214. PMID 15349872. 
^ Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007-01-30). "How common are the 'common' neurologic disorders?". Neurology 68 (5): 326–37. doi:10.1212/01.wnl.0000252807.38124.a3. PMID 17261678. 
^ Sander JW (2003). "The epidemiology of epilepsy revisited". Curr Opin Neurol 16 (2): 165–70. doi:10.1097/00019052-200304000-00008. PMID 12644744. 
^ Walczak TS, Leppik IE, D'Amelio M, Rarick J, So E, Ahman P, Ruggles K, Cascino GD, Annegers JF, Hauser WA (2001). "SIncidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study.". Neurology 56: 519–525. 
^ Lathers, C. and P. Schraeder (1990). Epilepsy and Sudden Death. Dekker, NY, NY.. 
^ Hitiris, N., R. Mohanraj, J. Norrie and M. J. Brodie (2007). "Mortality in epilepsy". Epilepsy Behavior 10: 363–376. doi:10.1016/j.yebeh.2007.01.005. 
^ Plioplys S, Dunn DW, Caplan R (2007). "10-year research update review: psychiatric problems in children with epilepsy". J Am Acad Child Adolesc Psychiatry 46 (11): 1389–402. doi:10.1097/chi.0b013e31815597fc. PMID 18049289. 
^ Levisohn PM (2007). "The autism-epilepsy connection". Epilepsia 48 (Suppl 9): 33–5. PMID 18047599. 
^ The National Society for Epilepsy (2009), What is Epilepsy?. Available from http://www.epilepsynse.org.uk/AboutEpilepsy/Whatisepilepsy (Accessed on 15 February 2009).
^ Bertrand D, Picard F, Le Hellard S, Weiland S, Favre I, Phillips H, et al. (2002). "How mutations in the nAChRs can cause ADNFLE epilepsy.". Epilepsia 43 Supple 5: 112–122. doi:10.1046/j.1528-1157.43.s.5.16.x. 
^ Loiseau P, Duche B, Cordova S, et al (1988). "Prognosis of benign childhood epilepsy with centro-temporal spikes. A follow-up of 168 patients". Epilepsia 29: 229–235. doi:10.1111/j.1528-1157.1988.tb03711.x. 
^ Panayiotopolous CP (2000). "Benign childhood epileptic syndromes with occipital spikes: New classification proposed by the ILAE". J Child Neurol 15: 548–552. doi:10.1177/088307380001500810. PMID 10961795. 
^ "Dravet Syndrome". http://www.dravet.com. Retrieved on 2007-12-16. 
^ Koutroumanidis M, Koepp MJ, Richardson MP, Camfield C, Agathonikou A, Ried S, et al (1998). "The variants of reading epilepsy. A clinical and video-EEG study of 17 patients with reading-induced seizures". Brain 121: 1409–1427. doi:10.1093/brain/121.8.1409. PMID 9712004. 
^ Rogers et al (1994). "Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis". Science 265: 648–651. doi:10.1126/science.8036512. PMID 8036512. 
^ Eadie MJ, Bladin PF (2001). A Disease Once Sacred: a History of the Medical Understanding of Epilepsy. 
^ Cascino GD (1994). "Epilepsy: contemporary perspectives on evaluation and treatment". Mayo Clinic Proc 69: 1199–1211. 
^ Engel J Jr (1996). "Surgery for seizures". NEJM 334: 647–652. doi:10.1056/NEJM199603073341008. PMID 8592530. 
^ Baker GA, Jacoby A, Buck D, et al (1997). "Quality in life in people with epilepsy: a European study". Epilepsia 38: 353–362. doi:10.1111/j.1528-1157.1997.tb01128.x. 
^ Camfiled C, Camfield P, Smith E, et al. (1986). "Asymptomatic children with epilepsy: little benefit from screening for anticonvulsant-induced liver, blood, or renal damage.". Neurology 36: 838–841. 
^ mattson RH, Cramer J, COllins JF. (1985). "Comparison of carbemazipine, phenobarbital, phenytoin, and primidone in complex partial seizures.". NEJM 313: 145–151. 
^ Kwan P, Brodie MJ. (2000). "Early identification of refractory epilepsy.". NEJM 342: 314–319. doi:10.1056/NEJM200002033420503. PMID 10660394. 
^ Birbeck GL, Hays RD, Cui X, Vickrey BG. (2002). "Seizure reduction and quality of life improvements in people with epilepsy". Epilepsia 43: 535–538. doi:10.1046/j.1528-1157.2002.32201.x. 
^ Berg AT, Langfitt JT, Spencer SS, Vickrey BG. (2007). "Stopping antiepileptic drugs after epilepsy surgery: a survey of U.S. epilepsy center neurologists". Epilepsy Behav 10: 219–222. doi:10.1016/j.yebeh.2006.12.001. 
^ Kelley K, Theodore WH (2005). "Prognosis 30 years after temporal lobectomy". Neurology 64 (11): 1974–6. doi:10.1212/01.WNL.0000163998.01543.CF. PMID 15955959. 
^ Wiebe S, Blume WT, Girvin JP, Eliasziw M. (2001). "A randomized, controlled trial of surgery for temporal-lobe epilepsy". N Engl J Med 345: 311–318. doi:10.1056/NEJM200108023450501. PMID 11484687. 
^ Theodore WH, Fisher RS (2004). "Brain stimulation for epilepsy". Lancet Neurol 3: 111–118. 
^ Regis, J., M. Rey, F. Bartolomei, V. Vladyka, R. Liscak, O. Schrottner and G. Pendl (2004). "Gamma knife surgery in mesial temporal lobe epilepsy: a prospective multicenter study". Epilepsia 45: 504–515. doi:10.1111/j.0013-9580.2004.07903.x. 
^ Takahashi, T. and Y. Tsukahara (1992). "Usefulness of blue sunglasses in photosensitive epilepsy". Epilepsia 33: 517–521. doi:10.1111/j.1528-1157.1992.tb01702.x. 
^ Barriaux, Marianne (2006-10-16). "Dogs trained to warn of an imminent epileptic fit". The Guardian. http://business.guardian.co.uk/story/0,,1923146,00.html. Retrieved on 2006-11-24. 
^ Cheuk D, Wong V (2006). "Acupuncture for epilepsy". Cochrane Database Syst Rev (2): CD005062. doi:10.1002/14651858.CD005062.pub2. PMID 16625622. 
^ Ramaratnam S, Baker GA, Goldstein LH (2005). "Psychological treatments for epilepsy". Cochrane Database Syst Rev (4): CD002029. doi:10.1002/14651858.CD002029.pub2. PMID 16235293. 
^ Ranganathan LN, Ramaratnam S (2005). "Vitamins for epilepsy". Cochrane Database Syst Rev (2): CD004304. doi:10.1002/14651858.CD004304.pub2. PMID 15846704. 
^ Ramaratnam S, Sridharan K (2000). "Yoga for epilepsy". Cochrane Database Syst Rev (3): CD001524. doi:10.1002/14651858.CD001524. PMID 10908505. 
^ Miriam H. Meisler and Jennifer A. Kearney (2005). "Sodium channel mutations in epilepsy and other neurological disorders". Journal of Clinical Investigation 115 (8): 2010–2017. doi:10.1172/JCI25466. PMID 16075041 doi:10.1172/JCI25466. 
^ Harper, Douglas (2001). "epilepsy". Online Etymological Dictionary. http://www.etymonline.com/index.php?term=epilepsy. Retrieved on 2005-06-05. 
^ When Epilepsy Goes By Another Name | epilepsy.com
^ Morbus sacer in Africa: some religious aspects of epilepsy in traditional cultures. Jilek-Aall L. PMID: 10080524 Retrieved 8 October 2006.
^ Hippocrates quotes
^ Epilepsy Foundation Driving and You - Can you drive an automobile if you have epilepsy?.
^ Epilepsy Foundation Driver Information by State
^ UK Epilepsy Action: Driving and Epilepsy, I've had a seizure. What should I do?
^ UK Driver and Vehicle Licensing Agency Guide to the Current Medical Standards Of Fitness to Drive. Full details for doctors regarding epilepsy are given in the Appendix. Information for drivers can be found in Medical Rules - Group 1 Licence Holders
^ UK Epilepsy Action: booklet with further details about driving PDF
^ Epilepsy Action (2009), Driving law relating to seizures. Available from http://www.epilepsy.org.uk/info/driving/lawseizure (Accessed on 15 February 2009)
^ "Hydrocephalus Fact Sheet", National Institute of Neurological Disorders and Stroke. (August 2005).
^ Cabot, Richard C. (1919) Physical diagnosis , William Wood and company, New York, 7th edition, 527 pages, page 5. (Google Books)
^ a b Eat your way to a better brain for your baby December 2005. Virtual Learning Environment (VLE)
^ "Man with tiny brain shocks doctors", New Scientist (2007-07-20).
^ Need For Increased Federal Funding of Type 1 Diabetes Research JDRF
^ Yadav YR, Mukerji G, Shenoy R, Basoor A, Jain G, Nelson A (2007). "Endoscopic management of hypertensive intraventricular haemorrhage with obstructive hydrocephalus". BMC Neurol 7: 1. doi:10.1186/1471-2377-7-1. PMID 17204141. PMC: 1780056. http://www.biomedcentral.com/1471-2377/7/1. 
^ wwww.spinabifidamoms.com
^ http://www.hydroassoc.org/media/stats
^ "Man with Almost No Brain Has Led Normal Life", Fox News (2007-07-25). Also see "Tiny brain, normal life; French doctors are puzzling over the case of 44-year-old civil servant who has led a quite normal life -- but with an extraordinarily tiny brain", Physorg.com (2007-07-20); "Tiny Brain, Normal Life", ScienceDaily (2007-07-24).
^ Man Lives Normal Life Despite Having Abnormal Brain
^ Brain of a white-collar worker. Feuillet, L., Dufour, H. & Pelletier, J., et al. The Lancet, Volume 370, Issue 9583, Page 262, 21 July 2007
^ The International Classification of Headache Disorders, 2nd Edition
^ "NINDS Migraine Information Page". National Institute of Neurological Disorders and Stroke, National Institutes of Health. http://www.ninds.nih.gov/disorders/migraine/migraine.htm. Retrieved on 2007-06-25. 
^ "Advances in Migraine Prophylaxis: Current State of the Art and Future Prospects" (PDF). National Headache Foundation (CME monograph). http://www.headaches.org/professional/educationresources/PDF/botoxcme.pdf. Retrieved on 2007-06-25. 
^ Gallagher RM, Cutrer FM (2002). "Migraine: diagnosis, management, and new treatment options". Am J Manag Care 8 (3 Suppl): S58–73. PMID 11859906. 
^ "Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache, January 2007,British Association for the Study of Headache" (PDF). http://216.25.100.131/upload/NS_BASH/BASH_guidelines_2007.pdf. Retrieved on 2007-06-25. 
^ Ogilvie AD, Russell MB, Dhall P, et al (1998). "Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura". Cephalalgia 18 (1): 23–6. doi:10.1046/j.1468-2982.1998.1801023.x. PMID 9601620. 
^ Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB (September 1999). "The relative role of genetic and environmental factors in migraine without aura". Neurology 53 (5): 995–9. PMID 10496258. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=10496258. 
^ Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB (March 1999). "The inheritance of migraine with aura estimated by means of structural equation modelling". J. Med. Genet. 36 (3): 225–7. PMID 10204850. PMC: 1734315. http://jmg.bmj.com/cgi/pmidlookup?view=long&pmid=10204850. 
^ a b c d e f Headache Classification Subcommittee of the International Headache Society (2004). "The International Classification of Headache Disorders: 2nd edition". Cephalalgia : an international journal of headache 24 Suppl 1: 9–160. doi:10.1111/j.1468-2982.2004.00653.x. PMID 14979299.  Complete supplement online
^ Headache Classification Subcommittee of the International Headache Society (2004). "The International Classification of Headache Disorders: 2nd edition". Cephalalgia : an international journal of headache 24 Suppl 1: 150. doi:10.1111/j.1468-2982.2004.00653.x. PMID 14979299.  Complete supplement online (see page 150)
^ http://headaches.about.com/cs/asktheclinian/f/122203_1f.htm
^ http://headaches.about.com/od/migrainediseas1/a/what_abdom_mx.htm
^ http://www.answers.com/topic/amitriptyline
^ http://www.webmd.com/migraines-headaches/abdominal-migraines-children-adults?page=2
^ http://www.medicinenet.com/topiramate/article.htm
^ http://digestive.niddk.nih.gov/ddiseases/pubs/cvs/index.htm#migraine
^ http://dictionary.webmd.com/terms/abdominal-migraine
^ Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001). "Prevalence and burden of migraine in the United States: data from the American Migraine Study II". Headache 41 (7): 646–57. doi:10.1046/j.1526-4610.2001.041007646.x. PMID 11554952. 
^ a b Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC (1993). "Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women". Headache 33 (7): 385–9. doi:10.1111/j.1526-4610.1993.hed3307385.x. PMID 8376100. 
^ (2004) "The International Classification of Headache Disorders: 2nd edition". Cephalalgia 24 Suppl 1: 9–160.
^ Brandes JL (2006). "The influence of estrogen on migraine: a systematic review". JAMA 295 (15): 1824–30. doi:10.1001/jama.295.15.1824. PMID 16622144. 
^ a b MacGregor EA, Hackshaw A (2004). "Prevalence of migraine on each day of the natural menstrual cycle". Neurology 63 (2): 351–3. PMID 15277635. 
^ Granella F, Sances G, Allais G, et al (2004). "Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres". Cephalalgia 24 (9): 707–16. doi:10.1111/j.1468-2982.2004.00741.x. PMID 15315526. 
^ Couturier EG, Bomhof MA, Neven AK, van Duijn NP (2003). "Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment". Cephalalgia 23 (4): 302–8. doi:10.1046/j.1468-2982.2003.00516.x. PMID 12716349. 
^ Martin VT, Wernke S, Mandell K, et al (2005). "Defining the relationship between ovarian hormones and migraine headache". Headache 45 (9): 1190–201. doi:10.1111/j.1526-4610.2005.00242.x. PMID 16178949. 
^ Kelman L (October 2004). "The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs". Headache 44 (9): 865–72. doi:10.1111/j.1526-4610.2004.04168.x. PMID 15447695. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0017-8748&date=2004&volume=44&issue=9&spage=865. Retrieved on 2008-08-30. 
^ Silberstein, Stephen D. (2005). Atlas Of Migraine And Other Headaches. London: Taylor & Francis Group. ISBN 1842142739. 
^ Mathew, Ninan T.; Evans, Randolph W. (2005). Handbook of headache. Hagerstown, MD: Lippincott Williams & Wilkins. ISBN 078175223X. 
^ Silberstein, Stephen D. (2002). Headache in Clinical Practice, 2nd Edition. London: Taylor & Francis Group. ISBN 1-901865-88-6. 
^ Kelman L (February 2006). "The postdrome of the acute migraine attack". Cephalalgia 26 (2): 214–20. doi:10.1111/j.1468-2982.2005.01026.x. PMID 16426278. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0333-1024&date=2006&volume=26&issue=2&spage=214. Retrieved on 2008-08-30. 
^ Lipton RB, Stewart WF, Celentano DD, Reed ML (1992). "Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis". Arch. Intern. Med. 152 (6): 1273–8. doi:10.1001/archinte.152.6.1273. PMID 1599358. 
^ Schreiber CP, Hutchinson S, Webster CJ, Ames M, RichardsonMS, Powers C (2004). "Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache". Arch. Intern. Med. 164 (16): 1769–72. doi:10.1001/archinte.164.16.1769. PMID 15364670. 
^ Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM (2006). "Does this patient with headache have a migraine or need neuroimaging?". JAMA 296 (10): 1274–83. doi:10.1001/jama.296.10.1274. PMID 16968852. 
^ Lipton RB, Dodick D, Sadovsky R, et al (2003). "A self-administered screener for migraine in primary care: The ID Migraine validation study". Neurology 61 (3): 375–82. PMID 12913201. 
^ a b c d e f g h Alexander Mauskop; Fox, Barry (2001). What Your Doctor May Not Tell You About(TM): Migraines: The Breakthrough Program That Can Help End Your Pain (What Your Doctor May Not Tell You About...(Paperback)). New York: Warner Books. ISBN 0-446-67826-0. 
^ Cohen AS, Goadsby PJ (2005). "Functional neuroimaging of primary headache disorders". Curr Pain Headache Rep 9 (2): 141–6. doi:10.1007/s11916-005-0053-0. PMID 15745626. 
^ Trigger Point Therapy for Headaches & Migraines, DeLaune, Valerie (New Harbinger: 2008) [1]
^ Lauritzen M (1994). "Pathophysiology of the migraine aura. The spreading depression theory". Brain 117 (Pt 1): 199–210. doi:10.1093/brain/117.1.199. PMID 7908596. 
^ Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G (2007). "Hypothalamic activation in spontaneous migraine attacks". Headache 47 (10): 1418–26. doi:10.1111/j.1526-4610.2007.00776.x. PMID 18052951. 
^ a b c d e Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J (2006). "Epidemiology of headache in Europe". Eur. J. Neurol. 13 (4): 333–45. doi:10.1111/j.1468-1331.2006.01184.x. PMID 16643310. 
^ Mortimer MJ, Kay J, Jaron A (1992). "Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria". Dev Med Child Neurol 34 (12): 1095–101. PMID 1451940. 
^ Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M (1989). "An epidemiologic study of headache among adolescents and young adults". JAMA 261 (15): e1197. doi:10.1001/jama.261.15.2211. PMID 2926969. 
^ Ziegler DK, Hassanein RS, Couch JR (1977). "Characteristics of life headache histories in a nonclinic population". Neurology 27 (3): 265–9. PMID 557763. 
^ SELBY G, LANCE JW (1960). "Observations on 500 cases of migraine and allied vascular headache". J. Neurol. Neurosurg. Psychiatr. 23: 23–32. doi:10.1136/jnnp.23.1.23. PMID 14444681. 
^ a b Anttila P, Metsähonkala L, Sillanpää M (2006). "Long-term trends in the incidence of headache in Finnish schoolchildren". Pediatrics 117 (6): e1197–201. doi:10.1542/peds.2005-2274. PMID 16740819. 
^ a b c Lipton RB, Stewart WF (1993). "Migraine in the United States: a review of epidemiology and health care use". Neurology 43 (6 Suppl 3): S6–10. PMID 8502385. 
^ a b Rasmussen BK, Olesen J (1992). "Migraine with aura and migraine without aura: an epidemiological study". Cephalalgia 12 (4): 221–8; discussion 186. doi:10.1046/j.1468-2982.1992.1204221.x. PMID 1525797. 
^ Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB (2003). "The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity". Cephalalgia 23 (7): 519–27. doi:10.1046/j.1468-2982.2003.00568.x. PMID 12950377. 
^ Bigal ME, Liberman JN, Lipton RB (2006). "Age-dependent prevalence and clinical features of migraine". Neurology 67 (2): 246–51. doi:10.1212/01.wnl.0000225186.76323.69. PMID 16864816. 
^ Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D (1991). "Age- and sex-specific incidence rates of migraine with and without visual aura". Am. J. Epidemiol. 134 (10): 1111–20. PMID 1746521. 
^ Wang SJ (2003). "Epidemiology of migraine and other types of headache in Asia". Curr Neurol Neurosci Rep 3 (2): 104–8. doi:10.1007/s11910-003-0060-7. PMID 12583837. 
^ Lavados PM, Tenhamm E (1997). "Epidemiology of migraine headache in Santiago, Chile: a prevalence study". Cephalalgia 17 (7): 770–7. doi:10.1046/j.1468-2982.1997.1707770.x. PMID 9399008. 
^ Ottman R, Lipton RB (1994). "Comorbidity of migraine and epilepsy". Neurology 44 (11): 2105–10. PMID 7969967. 
^ Kantor, D (2006-11-21). "MedlinePlus Medical Encyclopedia: Migraine". http://www.nlm.nih.gov/medlineplus/ency/article/000709.htm. Retrieved on 2008-04-04. 
^ link titleMigraine Linked to Celiac Disease
^ Migraine Headaches: Gluten Triggers Severe Headaches in Sensitive Individuals
^ Robert Milne MD and Blake More. "Headaches". 109. http://www.naturalnews.com/008797.html. 
^ "Low Tyramine Headache Diet" (PDF). National Headache Foundation. 2004. http://www.headaches.org/pdf/LowTyramineDiet.pdf. Retrieved on 2008-04-04. 
^ Holzhammer J, Wöber C (2006). "[Alimentary trigger factors that provoke migraine and tension-type headache]" (in German). Schmerz 20 (2): 151–9. doi:10.1007/s00482-005-0390-2. PMID 15806385. 
^ Prince PB, Rapoport AM, Sheftell FD, Tepper SJ, Bigal ME (2004). "The effect of weather on headache". Headache 44 (6): 596–602. doi:10.1111/j.1526-4610.2004.446008.x. PMID 15186304. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0017-8748&date=2004&volume=44&issue=6&spage=596. 
^ Cooke LJ, Rose MS, Becker WJ (2000). "Chinook winds and migraine headache". Neurology 54 (2): 302–7. PMID 10668687. 
^ Ravishankar K (2006). "'Hair wash' or 'head bath' triggering migraine - observations in 94 Indian patients". Cephalalgia 26 (11): 1330–4. doi:10.1111/j.1468-2982.2006.01223.x. PMID 17059440. 
^ a b c d e f g h i j k Kaniecki R, Lucas S. (2004 page=40-52), Treatment of primary headache: preventive treatment of migraine. In: Standards of care for headache diagnosis and treatment., National Headache Foundation 
^ Millichap JG, Yee MM (2003). "The diet factor in pediatric and adolescent migraine". Pediatr. Neurol. 28 (1): 9–15. doi:10.1016/S0887-8994(02)00466-6. PMID 12657413. 
^ a b c Brandes JL, Kudrow D, Stark SR, et al (2007). "Sumatriptan-naproxen for acute treatment of migraine: a randomized trial". JAMA 297 (13): 1443–54. doi:10.1001/jama.297.13.1443. PMID 17405970. 
^ a b Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M (2000). "Efficacy and safety of paracetamol in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study". Arch. Intern. Med. 160 (22): 3486–92. doi:10.1001/archinte.160.22.3486. PMID 11112243. 
^ Goldstein J, Hoffman HD, Armellino JJ, et al (1999). "Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of paracetamol, aspirin, and caffeine". Cephalalgia : an international journal of headache 19 (7): 684–91. doi:10.1046/j.1468-2982.1999.019007684.x. PMID 10524663. 
^ Center for Drug Evaluation and Research (1999-10-07). "Approval Letter, Application 20-802/S802" (PDF). U.S. Food and Drug Administration. http://www.fda.gov/cder/foi/appletter/1999/20802s02ltr.pdf. Retrieved on 2008-08-26. 
^ Ben (2006). "Managing Migraines". FDA Consumer Magazine.. 
^ "4.7.4.1 Treatment of acute migraine". British National Formulary (55 ed.). March 2008. pp. p.239. 
^ Colman I, Friedman BW, Brown MD, et al (June 2008). "Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence". BMJ 336 (7657): 1359–61. doi:10.1136/bmj.39566.806725.BE. PMID 18541610. 
^ Freitag, Frederick G., Cady, Roger, DiSerio, Frank, Elkind, Arthur, Gallagher, R. Michael, Goldstein, Jerome, Klapper, Jack A., Rapoport, Alan M., Sadowsky, Carl, Saper, Joel R. & Smith, Timothy R. "Comparative Study of a Combination of Isometheptene Mucate, Dichloralphenazone With Acetaminophen and Sumatriptan Succinate in the Treatment of Migraine." Headache: The Journal of Head and Face Pain 41 (4), 391-398.
^ Tepper SJ, Stillman MJ (September 2008). "Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine". Headache 48 (8): 1259–68. doi:10.1111/j.1526-4610.2008.01214.x. PMID 18808506. 
^ UpToDate.
^ Migraine News for February 2005, accessed January 4, 2008
^ RK Cady, CP Schreiber, ME Beach, CC Hart (2005). "Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase". Medical Science Monitor 11 (9). PMID 16127373.  See also summary poster.
^ Russo, Ethan (1998). Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain 76:3-8.
^ Diener H, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T, Gallai V, Göbel H, Hartung E, Jimenez M, Lange R, Manzoni G, Mueller-Schwefe G, Nappi G, Pinessi L, Prat J, Puca F, Titus F, Voelker M (2004). "Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks". Cephalalgia 24 (11): 475. doi:10.1111/j.1468-2982.2004.00783.x. PMID 15482357. 
^ Silberstein SD, Mannix LK, Goldstein J, et al (2008). "Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine". Neurology 71 (2): 114–21. doi:10.1212/01.wnl.0000316800.22949.20. PMID 18606965. 
^ a b Modi S, Lowder D (2006). "Medications for migraine prophylaxis". American Family Physician 73 (1): 72. PMID 16417067. 
^ Diener H, Limmroth V (2004). "Medication-overuse headache: a worldwide problem". The Lancet Neurology 3: 475. doi:10.1016/S1474-4422(04)00824-5. 
^ Fritsche G; Diener HC (November 2002). "Medication overuse headaches – what is new?". Expert Opin Drug Saf 1 (4): 331–8. doi:10.1517/14740338.1.4.331. PMID 12904133. http://www.informapharmascience.com/doi/abs/10.1517/14740338.1.4.331. 
^ a b P-HM van der Kuy, JJHM Lohman (2002). "A quantification of the placebo response in migraine prophylaxis". Cephalalgia 22 (4): 265–270. doi:10.1046/j.1468-2982.2002.00363.x. 
^ Holzhammer J, Wöber C (2006). "Alimentary trigger factors that provoke migraine and tension-type headache" (in German). Schmerz 20: 151. PMID 15806385. 
^ Migraine Linked to Celiac Disease
^ Migraine Headaches: Gluten Triggers Severe Headaches in Sensitive Individuals
^ Migraine Linked to Celiac Disease
^ Linde K, Rossnagel K (2004). "Propranolol for migraine prophylaxis". Cochrane Database Syst Rev: CD003225. doi:10.1002/14651858.CD003225.pub2. PMID 15106196. 
^ Chronicle E, Mulleners W (2004). "Anticonvulsant drugs for migraine prophylaxis". Cochrane Database Syst Rev: CD003226. doi:10.1002/14651858.CD003226.pub2. PMID 15266476. 
^ Steinman M, Bero L, Chren M, Landefeld C (2006). "Narrative review: the promotion of gabapentin: an analysis of internal industry documents". Ann Intern Med 145 (4): 284–93. PMID 16908919. 
^ Moja P, Cusi C, Sterzi R, Canepari C (2005). "Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches". Cochrane Database Syst Rev: CD002919. doi:10.1002/14651858.CD002919.pub2. PMID 16034880. 
^ Tomkins G, Jackson J, O'Malley P, Balden E, Santoro J (2001). "Treatment of chronic headache with antidepressants: a meta-analysis". Am J Med 111 (1): 54–63. doi:10.1016/S0002-9343(01)00762-8. PMID 11448661. 
^ Ziegler D, Hurwitz A, Hassanein R, Kodanaz H, Preskorn S, Mason J (1987). "Migraine prophylaxis. A comparison of propranolol and amitriptyline". Arch Neurol 44 (5): 486–9. PMID 3579659. 
^ http://www.webmd.com/content/article/98/105003.htm?z=1728_00000_1000_tn_04
^ a b Russo E (May 1998). "Cannabis for migraine treatment: the once and future prescription? An historical and scientific review". Pain 76 (1-2): 3–8. doi:10.1016/S0304-3959(98)00033-5. PMID 9696453. http://linkinghub.elsevier.com/retrieve/pii/S0304-3959(98)00033-5. Retrieved on 2008-08-30. 
^ Rozen T, Oshinsky M, Gebeline C, Bradley K, Young W, Shechter A, Silberstein S (2002). "Open label trial of coenzyme Q10 as a migraine preventive". Cephalalgia 22 (2): 137–41. doi:10.1046/j.1468-2982.2002.00335.x. PMID 11972582. 
^ Sándor PS, et al. (2005). "Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial". Neurology 64: 713–715. doi:10.1212/01.WNL.0000151975.03598.ED (inactive 2008-06-25). PMID 15728298. http://www.neurology.org/cgi/content/abstract/64/4/713. 
^ Pittler MH, Ernst E. (2004). "Feverfew for preventing migraine". Cochrane Database of Systematic Reviews (1): CD002286. doi:10.1002/14651858.CD002286.pub2. PMID 14973986. 
^ For example: Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH (2005). "Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention—a randomized, double-blind, multicentre, placebo-controlled study". Cephalalgia 25: 1031–41. doi:10.1111/j.1468-2982.2005.00950.x. PMID 16232154. 
^ Peikert A, Wilimzig C, Köhne-Volland R (1996). "Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study". Cephalalgia 16 (4): 257–63. doi:10.1046/j.1468-2982.1996.1604257.x. PMID 8792038. 
^ J Schoenen, J Jacquay, M Lenaerts (1998). "Effectiveness of high dose riboflavin in migraine prophylaxis: A randomized controlled trial". Neurology 150: 466–470. 
^ a b A Bianchi, S Salomone, F Caraci, V Pizza, R Bernardini, CC D'Amato (2004). "Role of Magnesium, Coenzyme Q10, Riboflavin, and Vitamin B12 in Migraine Prophylaxis". Vitamins and Hormones 69: 297–312. doi:10.1016/S0083-6729(04)69011-X. 
^ Riboflavin in Prophylactic Treatment of Migraine, EA Balbisi, EM Ambizas, U.S. Pharmacist Vol. 30, No. 05, accessed January 4, 2008.
^ P-HM van der Kuy, FWHM Merkus, JJHM Lohman, JWM ter Berg, PM Hooymans (2002). "Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study". Cephalalgia 22 (7): 513–519. doi:10.1046/j.1468-2982.2002.00412.x. 
^ Peres MF, Zukerman E, da Cunha Tanuri F, Moreira FR, Cipolla-Neto J (August 2004). "Melatonin, 3 mg, is effective for migraine prevention". Neurology 63 (4): 757. PMID 15326268. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=15326268. 
^ Guyuron B, Tucker T, Davis J (June 2002). "Surgical treatment of migraine headaches". Plast. Reconstr. Surg. 109 (7): 2183–9. doi:10.1097/00006534-200206000-00001. PMID 12045534. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0032-1052&volume=109&issue=7&spage=2183. 
^ Guyuron B, Kriegler JS, Davis J, Amini SB (January 2005). "Comprehensive surgical treatment of migraine headaches". Plast. Reconstr. Surg. 115 (1): 1–9. PMID 15622223. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0032-1052&volume=115&issue=1&spage=1. 
^ Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, Meier B, Windecker S (2004). "Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks". Neurology 62 (8): 1399–401. PMID 15111681. 
^ Samton J, Mauskop A (March 2006). "Treatment of headaches with botulinum toxin". Expert Rev Neurother 6 (3): 313–22. doi:10.1586/14737175.6.3.313. PMID 16533136. 
^ Cady R, Schreiber C (November 2007). "Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues". Headache 48: 900. doi:10.1111/j.1526-4610.2007.00953.x. PMID 18047501. 
^ Schürks M, Diener HC, Goadsby P (January 2008). "Update on the prophylaxis of migraine" ([dead link] – Scholar search). Curr Treat Options Neurol 10 (1): 398. doi:10.1007/s11940-008-0003-3. PMID 18325296. http://www.treatment-options.com/1092-8480/10/20. 
^ Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ (January 2004). "Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study". Brain 127 (Pt 1): 220–30. doi:10.1093/brain/awh022. PMID 14607792. 
^ http://technology.timesonline.co.uk/article/0,,20409-2237003.html
^ Mohammad, Yousef (2006-06-22). "Magnets Zap Migraines". 49th Annual Scientific Meeting of the American Headache Society. Retrieved on 2006-07-04. 
^ http://medicalcenter.osu.edu/mediaroom/press/article.cfm?ID=4059
^ Nestoriuc Y, Martin A (2007). "Efficacy of biofeedback for migraine: a meta-analysis". Pain 128 (1–2): 111–27. doi:10.1016/j.pain.2006.09.007. PMID 17084028. 

^ Bennett MH, French C, Schnabel A, Wasiak J, Kranke P (2008). "Normobaric and hyperbaric oxygen therapy for migraine and cluster headache". Cochrane Database Syst Rev (3): CD005219. doi:10.1002/14651858.CD005219.pub2. PMID 18646121. 
^ Eftedal OS, Lydersen S, Helde G, White L, Brubakk AO, Stovner LJ (2004). "A randomized, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine". Cephalalgia 24 (8): 639–44. doi:10.1111/j.1468-2982.2004.00724.x. PMID 15265052. 
^ Fife WP, Fife CE (1989). "Treatment of Migraine with Hyperbaric Oxygen". J. Hyperbaric Med 4 (1): 7–15. http://archive.rubicon-foundation.org/4386. Retrieved on 2008-08-06. 
^ Turville, A. E. (1934) "Refraction and migraine". Br. J. Physiol. Opt. 8, 62–89
^ Wilmut, E. B. (1956) "Migraine". Br. J. Physiol. Opt. 13, 93–97
^ http://www.essex.ac.uk/psychology/overlays/OPO.2002.22%20130-142.pdf
^ [2] (PDF)
^ [3]
^ http://www.medscape.com/viewarticle/533713
^ Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV (1998). "The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache.". Journal of Manipulative and Physiological Therapeutics 21(8) page=511-9. 
^ Bronfort G, Nilsson N, Haas M, Evans R, Goldsmith CH, Assendelft WJ, Bouter LM (2004). Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev. 3. 
^ http://www.thebowentechnique.com/content/migraine.htm
^ a b c Tuchin, PJ, Pollard, H & Bonello, R. (2000). ""A randomized controlled trial of chiropractic spinal manipulative therapy for migraine"". Journal of Manipulative and Physiological Therapeutics 23: 91. doi:10.1016/S0161-4754(00)90073-3. 
^ a b Biondi, DM (2005). "Physical Treatments for Headache: A Structured Review"". The Journal of Head and Face Pain 45,: 738-746.. 
^ Facco E, Liguori A, Petti F, et al (2007). "Traditional Acupuncture in Migraine: A Controlled, Randomized Study". Headache 48: 398. doi:10.1111/j.1526-4610.2007.00916.x. PMID 17868354. 
^ Melchart D, Thormaehlen J, Hager S, Liao J, Linde K, Weidenhammer W (2003). "Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial". J. Intern. Med. 253 (2): 181–8. doi:10.1046/j.1365-2796.2003.01081.x. PMID 12542558. 
^ Alexander Mauskop; Fox, Barry (2001). What Your Doctor May Not Tell You About: Migraines: The Breakthrough Program That Can Help End Your Pain (What Your Doctor May Not Tell You About...(Paperback)). New York: Warner Books. pp. 130. ISBN 0-446-67826-0. 
^ http://www.euvolution.com/articles/disease.html Evolution and the Origins of Disease
^ http://www.baillement.com/texte-migraine-evolutionary.pdf What is the evolutionary advantage of migraine?
^ http://www.baillement.com/texte-migraine-evolutionary.pdf What is the evolutionary advantage of migraine?
^ http://www.baillement.com/texte-migraine-evolutionary.pdf What is the evolutionary advantage of migraine?
^ http://www.baillement.com/texte-migraine-evolutionary.pdf What is the evolutionary advantage of migraine?
^ http://www.euvolution.com/articles/disease.html Evolution and the Origins of Disease
^ a b Etminan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ. 2005;330:63. PMID 15596418
^ Kurth, T; Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE (July 19 2006). "Migraine and risk of cardiovascular disease in women". Journal of the American Medical Association 296 (3): 283–91. doi:10.1001/jama.296.3.283. PMID 16849661. 
^ Becker C, Brobert GP, Almqvist PM, Johansson S, Jick SS, Meier CR. Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache. 2007;47(10):1374–84. PMID 18052947
^ Waters WE, Campbell MJ, Elwood PC. Migraine, headache, and survival in women. BMJ (Clin Res Ed). 1983;287:1442–1443. PMID 6416449
^ Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA. 2006;296:283–291.
·  ^ Finsterer J (2007). "Hematological manifestations of primary mitochondrial disorders". Acta Haematol. 118 (2): 88–98. doi:10.1159/000105676. PMID 17637511. 

·  ^ Lemonick MD (2006-11-05). "When cells stop working". TIME. http://www.time.com/time/magazine/printout/0,8816,1555122,00.html. 

·  ^ Tanaka M, Nishigaki Y, Fuku N, Ibi T, Sahashi K, Koga Y (2007). "Therapeutic potential of pyruvate therapy for mitochondrial diseases". Mitochondrion 7 (6): 399–401. doi:10.1016/j.mito.2007.07.002. PMID 17881297. 

·  ^ Keim B (2008-11-21). "New longevity drugs poised to tackle diseases of aging". Wired. http://blog.wired.com/wiredscience/2008/11/two-mice-on-tre.html.

^ "Dorlands Medical Dictionary:mononeuropathy". http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/five/000067367.htm. 
^ Types of MND at GPnotebook
^ Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 1994. 264(5166): p. 1772-5.
^ Brooks BR (1994). "El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors". J. Neurol. Sci. 124 Suppl: 96–107. PMID 7807156. 
^ "El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis - Requirements for Diagnosis". http://www.wfnals.org/guidelines/1998elescorial/elescorial1998criteria.htm. Retrieved on 2007-06-06. 
^ Belsh JM (2000). "ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers?". Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1 Suppl 1: S57–60. doi:10.1080/14660820052415925. PMID 11464928. 
^ "A Twitch of Potential". Time. http://www.time.com/time/pacific/magazine/article/0,13673,503060501-1186615,00.html. Retrieved on 2006-12-30. 
^ Waring, S.C et al (2004). "Incidence of Amyotrophic Lateral Sclerosis and of the Parkinsonism-Dementia Complex of Guam, 1950-1989". Neuroepidemiology 23 (4): 192–199. doi:10.1159/000078505. 
^ "Flying fox linked to disease - The Boston Globe". http://www.boston.com/news/science/articles/2003/12/09/flying_fox_linked_to_disease/. Retrieved on 2007-06-06. 
^ Miller G (2006). "Neurodegenerative disease. Guam's deadly stalker: on the loose worldwide?". Science 313 (5786): 428–31. doi:10.1126/science.313.5786.428. PMID 16873621. http://www.sciencemag.org/cgi/content/full/313/5786/428. 
^ http://www.guardian.co.uk/science/2008/nov/03/lithium-motor-neurone-disease-trial
·  ^ a b c d e f g h i j k l m n o p q Compston A, Coles A (April 2002). "Multiple sclerosis". Lancet 359 (9313): 1221–31. doi:10.1016/S0140-6736(02)08220-X. PMID 11955556. 

·  ^ a b Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F (July 2008). "Natural history of multiple sclerosis in a population-based cohort". Eur. J. Neurol. 15: 916. doi:10.1111/j.1468-1331.2008.02241.x. PMID 18637953. 

·  ^ a b Rosati G (April 2001). "The prevalence of multiple sclerosis in the world: an update". Neurol. Sci. 22 (2): 117–39. doi:10.1007/s100720170011. PMID 11603614. 

·  ^ a b c Charcot, J. Histologie de la sclerose en plaques. Gazette des hopitaux, Paris, 1868; 41: 554–555.

·  ^ a b c d e f g h i Ascherio A, Munger KL (April 2007). "Environmental risk factors for multiple sclerosis. Part I: the role of infection". Ann. Neurol. 61 (4): 288–99. doi:10.1002/ana.21117. PMID 17444504. 

·  ^ a b c d e f g h Lublin FD, Reingold SC (April 1996). "Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis". Neurology 46 (4): 907–11. PMID 8780061. 

·  ^ a b c d e f Weinshenker BG (1994). "Natural history of multiple sclerosis". Ann. Neurol. 36 Suppl: S6–11. doi:10.1002/ana.410360704. PMID 8017890. 

·  ^ a b Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (May 2005). "Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis". Lancet Neurol 4 (5): 281–8. doi:10.1016/S1474-4422(05)70071-5. PMID 15847841. 

·  ^ a b Santos EC, Yokota M, DiasNF (September 2007). "[Multiple sclerosis: study of patients with relapsing-remitting form registered at Minas Gerais Secretary of State for Health]" (in Portuguese). Arq Neuropsiquiatr 65 (3B): 885–8. PMID 17952303. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2007000500032&lng=en&nrm=iso&tlng=en. 

·  ^ Navarro S, Mondéjar-Marín B, Pedrosa-Guerrero A, Pérez-Molina I, Garrido-Robres JA, Alvarez-Tejerina A (2005). "[Aphasia and parietal syndrome as the presenting symptoms of a demyelinating disease with pseudotumoral lesions]" (in Spanish; Castilian). Rev Neurol 41 (10): 601–3. PMID 16288423. http://www.revneurol.com/LinkOut/formMedLine.asp?Refer=2005523&Revista=RevNeurol. 

·  ^ Jongen PJ (June 2006). "Psychiatric onset of multiple sclerosis". J. Neurol. Sci. 245 (1-2): 59–62. doi:10.1016/j.jns.2005.09.014. PMID 16631798. 

·  ^ Yetimalar Y, Seçil Y, InceogluAK, Eren S, Başoğlu M (July 2008). "Unusual primary manifestations of multiple sclerosis". N. Z. Med. J. 121 (1277): 47–59. PMID 18677330. 

·  ^ Hakiki B, Goretti B, Portaccio E, Zipoli V, Amato MP (August 2008). "'Subclinical MS': follow-up of four cases". Eur. J. Neurol. 15 (8): 858–61. doi:10.1111/j.1468-1331.2008.02155.x. PMID 18507677. 

·  ^ Lebrun C, Bensa C, Debouverie M, et al (February 2008). "Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile". J. Neurol. Neurosurg. Psychiatr. 79 (2): 195–8. doi:10.1136/jnnp.2006.108274. PMID 18202208. 

·  ^ a b Freeman JA (April 2001). "Improving mobility and functional independence in persons with multiple sclerosis". J. Neurol. 248 (4): 255–9. doi:10.1007/s004150170198. PMID 11374088. http://link.springer.de/link/service/journals/00415/bibs/1248004/12480255.htm. 

·  ^ Merson RM, Rolnick MI (August 1998). "Speech-language pathology and dysphagia in multiple sclerosis". Phys Med Rehabil Clin N Am 9 (3): 631–41. PMID 9894114. 

·  ^ Kaur P, Bennett JL (2007). "Optic neuritis and the neuro-ophthalmology of multiple sclerosis". Int. Rev. Neurobiol. 79: 633–63. doi:10.1016/S0074-7742(07)79028-1. PMID 17531862. 

·  ^ Pöllmann W, Feneberg W (2008). "Current management of pain associated with multiple sclerosis". CNS Drugs 22 (4): 291–324. doi:10.2165/00023210-200822040-00003. PMID 18336059. 

·  ^ a b Henze T (August 2005). "Managing specific symptoms in people with multiple sclerosis" (PDF). Int MS J 12 (2): 60–8. PMID 16417816. http://www.msforumonline.net/journal/download/default.aspx?pdf=20051260.pdf. 

·  ^ Andrews KL, Husmann DA (December 1997). "Bladder dysfunction and management in multiple sclerosis". Mayo Clin. Proc. 72 (12): 1176–83. doi:10.4065/72.12.1176. PMID 9413302. 

·  ^ Bobholz JA, Rao SM (June 2003). "Cognitive dysfunction in multiple sclerosis: a review of recent developments". Curr. Opin. Neurol. 16 (3): 283–8. doi:10.1097/01.wco.0000073928.19076.84 (inactive 2009-04-04). PMID 12858063. 

·  ^ de Seze J, Zephir H, Hautecoeur P, Mackowiak A, Cabaret M, Vermersch P (November 2006). "Pathologic laughing and intractable hiccups can occur early in multiple sclerosis". Neurology 67 (9): 1684–6. doi:10.1212/01.wnl.0000242625.75753.69. PMID 17101907. 

·  ^ Kurtzke JF (1983). "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)". Neurology 33 (11): 1444–52. PMID 6685237. 

·  ^ a b Tataru N, Vidal C, Decavel P, Berger E, Rumbach L (2006). "Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis". Neuroepidemiology 27 (1): 28–32. doi:10.1159/000094233. PMID 16804331. 

·  ^ Confavreux C (May 2002). "Infections and the risk of relapse in multiple sclerosis". Brain 125 (Pt 5): 933–4. doi:10.1093/brain/awf146. PMID 11960883. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11960883. 

·  ^ Buljevac D, Flach HZ, Hop WC, et al (May 2002). "Prospective study on the relationship between infections and multiple sclerosis exacerbations". Brain 125 (Pt 5): 952–60. doi:10.1093/brain/awf098. PMID 11960885. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11960885. 

·  ^ Buljevac D, Hop WC, Reedeker W, et al (September 2003). "Self reported stressful life events and exacerbations in multiple sclerosis: prospective study". BMJ 327 (7416): 646. doi:10.1136/bmj.327.7416.646. PMID 14500435. 

·  ^ Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (August 2006). "Relationship between stress and relapse in multiple sclerosis: Part I. Important features". Mult. Scler. 12 (4): 453–64. doi:10.1191/1352458506ms1295oa. PMID 16900759. http://msj.sagepub.com/cgi/pmidlookup?view=long&pmid=16900759. 

·  ^ Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (August 2006). "Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships". Mult. Scler. 12 (4): 465–75. doi:10.1191/1352458506ms1296oa. PMID 16900760. http://msj.sagepub.com/cgi/pmidlookup?view=long&pmid=16900760. 

·  ^ Worthington J, Jones R, Crawford M, Forti A (February 1994). "Pregnancy and multiple sclerosis--a 3-year prospective study". J. Neurol. 241 (4): 228–33. doi:10.1007/BF00863773. PMID 8195822. 

·  ^ Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S (February 2001). "Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group". N. Engl. J. Med. 344 (5): 319–26. PMID 11172162. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=11172162&promo=ONFLNS19. 

·  ^ Martinelli V (2000). "Trauma, stress and multiple sclerosis". Neurol. Sci. 21 (4 Suppl 2): S849–52. doi:10.1007/s100720070024. PMID 11205361. http://link.springer-ny.com/link/service/journals/10072/bibs/00214%20Suppl%202/0021S849.htm. 

·  ^ Sibley WA, Bamford CR, Clark K, Smith MS, Laguna JF (July 1991). "A prospective study of physical trauma and multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 54 (7): 584–9. doi:10.1136/jnnp.54.7.584. PMID 1895121. 

·  ^ Smith KJ, McDonald WI (October 1999). "The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease". Philos. Trans. R. Soc. Lond., B, Biol. Sci. 354 (1390): 1649–73. doi:10.1098/rstb.1999.0510. PMID 10603618. 

·  ^ Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M (April 2006). "Secondary progressive multiple sclerosis: current knowledge and future challenges". Lancet Neurol 5 (4): 343–54. doi:10.1016/S1474-4422(06)70410-0. PMID 16545751. 

·  ^ a b c d Miller DH, Leary SM (October 2007). "Primary-progressive multiple sclerosis". Lancet Neurol 6 (10): 903–12. doi:10.1016/S1474-4422(07)70243-0. PMID 17884680. 

·  ^ Fontaine B (September 2001). "[Borderline forms of multiple sclerosis]" (in French). Rev. Neurol. (Paris) 157 (8-9 Pt 2): 929–34. PMID 11787357. http://www.masson.fr/masson/MDOI-RN-09-2001-157-8-9-0035-3787-101019-ART68. 

·  ^ Capello E, Mancardi GL (November 2004). "Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis". Neurol. Sci. 25 Suppl 4: S361–3. doi:10.1007/s10072-004-0341-1. PMID 15727234. 

·  ^ Hainfellner JA, Schmidbauer M, Schmutzhard E, Maier H, Budka H (December 1992). "Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis". J. Neurol. Neurosurg. Psychiatr. 55 (12): 1194–6. doi:10.1136/jnnp.55.12.1194. PMID 1343820. 

·  ^ Stark W, Huppke P, Gärtner J (December 2008). "Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence". J. Neurol. 255 Suppl 6: 119–22. doi:10.1007/s00415-008-6022-x. PMID 19300972. 

·  ^ O'Riordan JI (June 1997). "Central nervous system white matter diseases other than multiple sclerosis". Curr. Opin. Neurol. 10 (3): 211–4. PMID 9229127. 

·  ^ Trojano M, Paolicelli D (November 2001). "The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes". Neurol. Sci. 22 Suppl 2: S98–102. doi:10.1007/s100720100044. PMID 11794488. http://link.springer-ny.com/link/service/journals/10072/bibs/122%20Suppl%202000/122%20Suppl%2020S98.htm. 

·  ^ Poser CM, Brinar VV (June 2004). "Diagnostic criteria for multiple sclerosis: an historical review". Clin Neurol Neurosurg 106 (3): 147–58. doi:10.1016/j.clineuro.2004.02.004. PMID 15177763. 

·  ^ a b c d McDonaldWI, Compston A, Edan G, et al (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Ann. Neurol. 50 (1): 121–7. doi:10.1002/ana.1032. PMID 11456302. 

·  ^ Rashid W, Miller DH (February 2008). "Recent advances in neuroimaging of multiple sclerosis". Semin Neurol 28 (1): 46–55. doi:10.1055/s-2007-1019127. PMID 18256986. 

·  ^ Link H, Huang YM (November 2006). "Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness". J. Neuroimmunol. 180 (1-2): 17–28. doi:10.1016/j.jneuroim.2006.07.006. PMID 16945427. 

·  ^ Gronseth GS, Ashman EJ (May 2000). "Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology 54 (9): 1720–5. PMID 10802774. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=10802774. 

·  ^ Pascual AM, Martínez-Bisbal MC, Boscá I, et al (July 2007). "Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis". Neurology 69 (1): 63–7. doi:10.1212/01.wnl.0000265054.08610.12. PMID 17606882. 

·  ^ a b Chari DM (2007). "Remyelination in multiple sclerosis". Int. Rev. Neurobiol. 79: 589–620. doi:10.1016/S0074-7742(07)79026-8. PMID 17531860. 

·  ^ Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (June 2000). "Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination". Ann. Neurol. 47 (6): 707–17. doi:10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q. PMID 10852536. 

·  ^ a b c d Kurtzke JF (October 1993). "Epidemiologic evidence for multiple sclerosis as an infection". Clin. Microbiol. Rev. 6 (4): 382–427. PMID 8269393. PMC: 358295. http://cmr.asm.org/cgi/pmidlookup?view=long&pmid=8269393. 

·  ^ a b c d e f g h Marrie RA (December 2004). "Environmental risk factors in multiple sclerosis aetiology". Lancet Neurol 3 (12): 709–18. doi:10.1016/S1474-4422(04)00933-0. PMID 15556803. 

·  ^ a b c d e Ascherio A, Munger KL (June 2007). "Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors". Ann. Neurol. 61 (6): 504–13. doi:10.1002/ana.21141. PMID 17492755. 

·  ^ a b Brissaud O, Palin K, Chateil JF, Pedespan JM (September 2001). "Multiple sclerosis: pathogenesis and manifestations in children" (in French). Arch Pediatr 8 (9): 969–78. doi:10.1016/S0929-693X(01)00564-4. PMID 11582940. 

·  ^ a b c Alonso A, Hernán MA (July 2008). "Temporal trends in the incidence of multiple sclerosis: a systematic review". Neurology 71 (2): 129–35. doi:10.1212/01.wnl.0000316802.35974.34. PMID 18606967. 

·  ^ Aladro Y, Alemany MJ, Pérez-Vieitez MC, et al (2005). "Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain". Neuroepidemiology 24 (1-2): 70–5. doi:10.1159/000081052. PMID 15459512. 

·  ^ a b Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Rosati G (April 2001). "Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory". Neurol. Sci. 22 (2): 163–5. doi:10.1007/s100720170017. PMID 11603620. http://link.springer-ny.com/link/service/journals/10072/bibs/1022002/10220163.htm. 

·  ^ Hammond SR, English DR, McLeod JG (May 2000). "The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia". Brain 123 (Pt 5): 968–74. doi:10.1093/brain/123.5.968. PMID 10775541. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=10775541. 

·  ^ Rothwell PM, Charlton D (1998). "High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition". J. Neurol. Neurosurg. Psychiatr. 64 (6): 730–5. doi:10.1136/jnnp.64.6.730. PMID 9647300. 

·  ^ Dyment DA, Ebers GC, Sadovnick AD (Feb 2004). "Genetics of multiple sclerosis". Lancet Neurol 3 (92): 104–10. doi:10.1016/S1474-4422(03)00663-X. PMID 14747002. 

·  ^ Sadovnick AD, Ebers GC, Dyment DA, RischNJ (June 1996). "Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group". Lancet 347 (9017): 1728–30. PMID 8656905. 

·  ^ a b Svejgaard A (June 2008). "The immunogenetics of multiple sclerosis". Immunogenetics 60 (6): 275–86. doi:10.1007/s00251-008-0295-1. PMID 18461312. 

·  ^ Hafler DA, Compston A, Sawcer S, et al (August 2007). "Risk alleles for multiple sclerosis identified by a genomewide study". N. Engl. J. Med. 357 (9): 851–62. doi:10.1056/NEJMoa073493. PMID 17660530. 

·  ^ Weber F, Fontaine B, Cournu-Rebeix I, et al (April 2008). "IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations". Genes Immun. 9 (3): 259–63. doi:10.1038/gene.2008.14. PMID 18354419. 

·  ^ Anaya JM, Gómez L, Castiblanco J (2006). "Is there a common genetic basis for autoimmune diseases?". Clin. Dev. Immunol. 13 (2-4): 185–95. doi:10.1080/17402520600876762. PMID 17162361. 

·  ^ Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ (September 2008). "IL-21 signaling is critical for the development of type I diabetes in the NOD mouse". Proc. Natl. Acad. Sci. U.S.A. 105: 14028. doi:10.1073/pnas.0804358105. PMID 18779574. 

·  ^ Aulchenko YS, HoppenbrouwersIA, Ramagopalan SV, et al (December 2008). "Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis". Nat. Genet. 40 (12): 1402–3. doi:10.1038/ng.251. PMID 18997785. 

·  ^ Palacios R, Aguirrezabal I, Fernandez-Diez B, Brieva L, Villoslada P (October 2005). "Chromosome 5 and multiple sclerosis". J. Neuroimmunol. 167 (1-2): 1–3. doi:10.1016/j.jneuroim.2005.06.023. PMID 16099057. 

·  ^ Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M (February 1966). "Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation". J. Neurol. Neurosurg. Psychiatr. 29 (1): 60–8. doi:10.1136/jnnp.29.1.60. PMID 5910580. 

·  ^ Fleming J, Fabry Z (February 2007). "The hygiene hypothesis and multiple sclerosis". Ann. Neurol. 61 (2): 85–9. doi:10.1002/ana.21092. PMID 17315205. 

·  ^ Gilden DH (March 2005). "Infectious causes of multiple sclerosis". Lancet Neurol 4 (3): 195–202. doi:10.1016/S1474-4422(05)01017-3. PMID 15721830. 

·  ^ Christensen T (June 2007). "Human herpesviruses in MS" (PDF). Int MS J 14 (2): 41–7. PMID 17686342. http://www.msforumonline.net/journal/download/default.aspx?pdf=20071441.pdf. 

·  ^ Sotelo J, Martínez-Palomo A, Ordoñez G, Pineda B (March 2008). "Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis". Ann. Neurol. 63 (3): 303–11. doi:10.1002/ana.21316. PMID 18306233. 

·  ^ Lünemann JD, Kamradt T, Martin R, Münz C (July 2007). "Epstein-barr virus: environmental trigger of multiple sclerosis?". J. Virol. 81 (13): 6777–84. doi:10.1128/JVI.00153-07. PMID 17459939. 

·  ^ Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C (October 2001). "Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases". Ann. Neurol. 50 (4): 434–42. doi:10.1002/ana.1131. PMID 11601494. 

·  ^ Christensen T (May 2006). "The role of EBV in MS pathogenesis" (PDF). Int MS J 13 (2): 52–7. PMID 16635422. http://www.msforumonline.net/journal/download/default.aspx?pdf=20061352.pdf. 

·  ^ Yao SY, Stratton CW, Mitchell WM, Sriram S (May 2001). "CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens". Neurology 56 (9): 1168–76. PMID 11342681. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=11342681. 

·  ^ Islam T, Gauderman WJ, Cozen W, Mack TM (July 2007). "Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins". Neurology 69 (4): 381–8. doi:10.1212/01.wnl.0000268266.50850.48. PMID 17646631. 

·  ^ van der Mei IA, Ponsonby AL, Dwyer T, et al (August 2003). "Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study". BMJ 327 (7410): 316. doi:10.1136/bmj.327.7410.316. PMID 12907484. 

·  ^ Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (December 2006). "Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis". JAMA 296 (23): 2832–8. doi:10.1001/jama.296.23.2832 (inactive 2009-04-04). PMID 17179460. 

·  ^ Li J, Johansen C, Brønnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J (March 2004). "The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark". Neurology 62 (5): 726–9. PMID 15007121. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=15007121. 

·  ^ Franklin GM, Nelson L (October 2003). "Environmental risk factors in multiple sclerosis: causes, triggers, and patient autonomy". Neurology 61 (8): 1032–4. PMID 14581658. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=14581658. 

·  ^ Koch M, De Keyser J (April 2006). "Uric acid in multiple sclerosis". Neurol. Res. 28 (3): 316–9. doi:10.1179/016164106X98215. PMID 16687059. 

·  ^ Spitsin S, Koprowski H (2008). "Role of uric acid in multiple sclerosis". Curr. Top. Microbiol. Immunol. 318: 325–42. doi:10.1007/978-3-540-73677-6_13. PMID 18219824. 

·  ^ Mattle HP, Lienert C, Greeve I (September 2004). "[Uric acid and multiple sclerosis]" (in German). Ther Umsch 61 (9): 553–5. PMID 15493114. 

·  ^ Ascherio A, Munger K (February 2008). "Epidemiology of multiple sclerosis: from risk factors to prevention". Semin Neurol 28 (1): 17–28. doi:10.1055/s-2007-1019126. PMID 18256984. 

·  ^ Methylprednisolone Oral. US National Library of Medicine (Medline) (2003-04-01). Retrieved on 2007-09-01.

·  ^ Methylprednisolone Sodium Succinate Injection. US National Library of Medicine (Medline) (2003-04-01). Retrieved on 2007-09-01.

·  ^ Brusaferri F, Candelise L (2000). "Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials". J. Neurol. 247 (6): 435–42. doi:10.1007/s004150070172. PMID 10929272. 

·  ^ Dovio A, Perazzolo L, Osella G, et al (2004). "Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis". J. Clin. Endocrinol. Metab. 89 (10): 4923–8. doi:10.1210/jc.2004-0164. PMID 15472186. 

·  ^ Uttner I, Müller S, Zinser C, et al (2005). "Reversible impaired memory induced by pulsed methylprednisolone in patients with MS". Neurology 64 (11): 1971–3. doi:10.1212/01.WNL.0000163804.94163.91. PMID 15955958. 

·  ^ Jacobs LD, Beck RW, Simon JH, et al. (2000). "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group". N Engl J Med 343 (13): 898–904. doi:10.1056/NEJM200009283431301. PMID 11006365. 

·  ^ Comi G, Filippi M, Barkhof F, et al. (2001). "Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study". Lancet 357 (9268): 1576–82. doi:10.1016/S0140-6736(00)04725-5. PMID 11377645. 

·  ^ Kappos L, Freedman MS, Polman CH, et al. (2007). "Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study". Lancet 370 (9585): 389–97. doi:10.1016/S0140-6736(07)61194-5. PMID 17679016. 

·  ^ Ruggieri M, Avolio C, Livrea P, Trojano M (2007). "Glatiramer acetate in multiple sclerosis: a review". CNS Drug Rev 13 (2): 178–91. doi:10.1111/j.1527-3458.2007.00010.x. PMID 17627671. 

·  ^ a b Munari L, Lovati R, Boiko A (2004). "Therapy with glatiramer acetate for multiple sclerosis". Cochrane Database Syst Rev (1): CD004678. doi:10.1002/14651858.CD004678. PMID 14974077. 

·  ^ Rice GP, Incorvaia B, Munari L, et al (2001). "Interferon in relapsing-remitting multiple sclerosis". Cochrane Database Syst Rev (4): CD002002. doi:10.1002/14651858.CD002002. PMID 11687131. 

·  ^ a b Martinelli Boneschi F, Rovaris M, Capra R, Comi G (2005). "Mitoxantrone for multiple sclerosis". Cochrane Database Syst Rev (4): CD002127. doi:10.1002/14651858.CD002127.pub2. PMID 16235298. 

·  ^ Johnson KP (2007). "Control of multiple sclerosis relapses with immunomodulating agents". J. Neurol. Sci. 256 Suppl 1: S23–8. doi:10.1016/j.jns.2007.01.060. PMID 17350652. 

·  ^ Natalizumab reduces MS severity - http://www.abstracts2view.com/aan2008chicago/view.php?nu=AAN08L_P04.169

·  ^ Gonsette RE (2007). "Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis". Expert opinion on pharmacotherapy 8 (8): 1103–16. doi:10.1517/14656566.8.8.1103. PMID 17516874. 

·  ^ Murray TJ (2006). "The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?". Expert opinion on drug safety 5 (2): 265–74. doi:10.1517/14740338.5.2.265. PMID 16503747. 

·  ^ Leary SM, Thompson AJ (2005). "Primary progressive multiple sclerosis: current and future treatment options". CNS drugs 19 (5): 369–76. PMID 15907149. 

·  ^ Sládková T, Kostolanský F (2006). "The role of cytokines in the immune response to influenza A virus infection". Acta Virol. 50 (3): 151–62. PMID 17131933. 

·  ^ Primetherapeutics - serious liver damage per FDA - Primetherapeutics

·  ^ Betaseron [package insert]. Montville, NJ: Berlex Inc; 2003

·  ^ Rebif [package insert]. Rockland, MA: Serono Inc; 2005.

·  ^ Avonex [package insert]. Cambridge, MA: Biogen Inc; 2003

·  ^ a b Fox EJ (2006). "Management of worsening multiple sclerosis with mitoxantrone: a review". Clinical therapeutics 28 (4): 461–74. doi:10.1016/j.clinthera.2006.04.013. PMID 16750460. 

·  ^ Kleinschmidt-DeMasters BK, Tyler KL (2005). "Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis". N Engl J Med 353 (4): 369–74. doi:10.1056/NEJMoa051782. PMID 15947079.  Free full text with registration

·  ^ Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005). "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". N Engl J Med 353 (4): 375–81. doi:10.1056/NEJMoa051847. PMID 15947078.  Free full text with registration

·  ^ "Brain Infections Return for Multiple Sclerosis Drug Tysabri". 2008-08-01. http://blogs.wsj.com/health/2008/08/01/brain-infections-return-for-multiple-sclerosis-drug-tysabri. Retrieved on 2008-08-01. 

·  ^ Kesselring J, Beer S (2005). "Symptomatic therapy and neurorehabilitation in multiple sclerosis". Lancet neurology 4 (10): 643–52. doi:10.1016/S1474-4422(05)70193-9. PMID 16168933. 

·  ^ The RoyalCollege of Physicians (2004). Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care. Salisbury, Wiltshire: Sarum ColourView Group. ISBN 1 86016 182 0. Free full text (2004-08-13). Retrieved on 2007-10-01.

·  ^ Farinotti M, Simi S, Di Pietrantonj C, et al. (2007). "Dietary interventions for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD004192. doi:10.1002/14651858.CD004192.pub2. PMID 17253500. 

·  ^ Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E (2006). "Cannabis use in patients with multiple sclerosis". Mult. Scler. 12 (5): 646–51. doi:10.1177/1352458506070947. PMID 17086912. 

·  ^ Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ (2005). "Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up". J. Neurol. Neurosurg. Psychiatr. 76 (12): 1664–9. doi:10.1136/jnnp.2005.070136. PMID 16291891. 

·  ^ Bennett M, Heard R (2004). "Hyperbaric oxygen therapy for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD003057. doi:10.1002/14651858.CD003057.pub2. PMID 14974004. 

·  ^ Oken BS, Kishiyama S, Zajdel D, et al. (2004). "Randomized controlled trial of yoga and exercise in multiple sclerosis". Neurology 62 (11): 2058–64. PMID 15184614. 

·  ^ a b c Phadke JG (May 1987). "Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland". J. Neurol. Neurosurg. Psychiatr. 50 (5): 523–31. doi:10.1136/jnnp.50.5.523. PMID 3495637. 

·  ^ Stern M (February 2005). "Aging with multiple sclerosis". Phys Med Rehabil Clin N Am 16 (1): 219–34. doi:10.1016/j.pmr.2004.06.010. PMID 15561552. 

·  ^ Myhr KM, Riise T, Vedeler C, et al (February 2001). "Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension". Mult. Scler. 7 (1): 59–65. PMID 11321195. http://msj.sagepub.com/cgi/pmidlookup?view=long&pmid=11321195. 

·  ^ Compston A (October 1988). "The 150th anniversary of the first depiction of the lesions of multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 51 (10): 1249–52. doi:10.1136/jnnp.51.10.1249. PMID 3066846. 

·  ^ Medaer R (September 1979). "Does the history of multiple sclerosis go back as far as the 14th century?". Acta Neurol. Scand. 60 (3): 189–92. PMID 390966. 

·  ^ Holmøy T (2006). "A Norse contribution to the history of neurological diseases". Eur. Neurol. 55 (1): 57–8. doi:10.1159/000091431. PMID 16479124. 

·  ^ Firth, D (1948). The Case of August D`Esté. Cambridge: CambridgeUniversity Press. 

·  ^ a b Pearce JM (2005). "Historical descriptions of multiple sclerosis". Eur. Neurol. 54 (1): 49–53. doi:10.1159/000087387. PMID 16103678. 

·  ^ Barbellion, Wilhelm Nero Pilate (1919). The Journal of a Disappointed Man.New York: George H. Doran. 

·  ^ United Kingdom early Mitoxantrone Copaxone trial. Onyx Healthcare (2006-01-01). Retrieved on 2007-09-02.

·  ^ Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN. Genzyme (2007-02-01). Retrieved on 2007-09-02.

·  ^ Daclizumab. PDL Biopharma (2006-01-01). Retrieved on 2007-09-02.

·  ^ Treatment of Multiple Sclerosis Using Over the Counter Inosine. ClinicalTrials.gov (2006-03-16). Retrieved on 2007-09-02.

·  ^ Efficacy and Safety of BG00012 in Relapsing-Remitting Multiple Sclerosis. ClinicalTrials.gov (2007-09-01). Retrieved on 2007-11-12.

·  ^ Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis. ClinicalTrials.gov (2006-02-09). Retrieved on 2007-09-02.

·  ^ The CAMMS223 Trial Investigators (2008). "Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis". N Engl J Med 359 (17): 1786–1801. doi:10.1056/NEJMoa0802670. PMID 18946064. 

·  ^ Polman C, Barkhof F, Sandberg-Wollheim M, Linde A, Nordle O, Nederman T (2005). "Treatment with laquinimod reduces development of active MRI lesions in relapsing MS". Neurology 64 (6): 987–91. doi:10.1212/01.WNL.0000154520.48391.69 (inactive 2009-04-04). PMID 15781813. 

·  ^ Darlington CL (2005). "Technology evaluation: NeuroVax, Immune Response Corp". Curr. Opin. Mol. Ther. 7 (6): 598–603. PMID 16370383. 

·  ^ Agrawal YP (2005). "Low dose naltrexone therapy in multiple sclerosis". Med. Hypotheses 64 (4): 721–4. doi:10.1016/j.mehy.2004.09.024. PMID 15694688. 

·  ^ search of clinicaltrials.gov data-base for Low dose naltrexone Multiple Sclerosis

·  ^ 2007 clinical trial using LDN

·  ^ Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G (2008). "A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.". Multiple Sclerosis 14 (8): 1076–83. doi:10.1177/1352458508095828. PMID 18728058. 

·  ^ Albrecht P, Fröhlich R, Hartung HP, KieseierBC, Methner A (2007). "Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis". J Neurol Online: 1595. doi:10.1007/s00415-007-0538-3. PMID 17987252. 

·  ^ Gordon-Lipkin E, Chodkowski B, Reich DS et al (October 2007). "Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis". Neurology 69 (16): 1603–09. doi:10.1212/01.wnl.0000295995.46586.ae. PMID 17938370. 

·  ^ Thangarajh M, Gomez-Rial J, HedströmAK, et al (August 2008). "Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis". Mult. Scler. 14: 1208. doi:10.1177/1352458508095729. PMID 18755821.

·  ^ a b Conti-Fine BM, Milani M, Kaminski HJ (2006). "Myasthenia gravis: past, present, and future". J. Clin. Invest. 116 (11): 2843–54. doi:10.1172/JCI29894. PMID 17080188. 

·  ^ Jaretzki A, Barohn RJ, Ernstoff RM, et al (2000). "Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America". Neurology 55 (1): 16–23. PMID 10891897. http://www.neurology.org/cgi/content/full/55/1/16. 

·  ^ a b c d e Scherer K, Bedlack RS, Simel DL. (2005). "Does this patient have myasthenia gravis?". JAMA 293 (15): 1906–14. doi:10.1001/jama.293.15.1906. PMID 15840866. 

·  ^ Bedlack RS, Sanders DB. (2000). "How to handle myasthenic crisis. Essential steps in patient care.". Postgrad Med 107 (4): 211–4, 220–2. PMID 10778421. http://www.postgradmed.com/issues/2000/04_00/bedlack.htm. 

·  ^ Patrick J, Lindstrom J. Autoimmune response to acetylcholine receptor. Science (1973) 180:871–2.

·  ^ a b Losen M, Stassen MH, Martínez-Martínez P, et al. (2005). "Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis". Brain 128: 2327–37. doi:10.1093/brain/awh612. PMID 16150851. 

·  ^ a b Baets, M.H.; H.J.G.H. Oosterhuis (1993). Myasthenia gravis. DRD Press. pp. 158. ISBN 3805547366. 

·  ^ Seybold ME (1986). "The office Tensilon test for ocular myasthenia gravis". Arch Neurol 43: 842–3. PMID 3729766. 

·  ^ de Kraker M, Kluin J, Renken N, Maat AP, Bogers AJ (2005). "CT and myasthenia gravis: correlation between mediastinal imaging and histopathological findings". Interact Cardiovasc Thorac Surg 4: 267–71. doi:10.1510/icvts.2004.097246. PMID 17670406. 

·  ^ Thieben MJ, Blacker DJ, Liu PY, Harper CM Jr, Wijdicks EF (2005). "Pulmonary function tests and blood gases in worsening myasthenia gravis". Muscle Nerve 32: 664–667. doi:10.1002/mus.20403. PMID 16025526. 

·  ^ a b c Warrell, David A; Timothy M Cox, et al (2003). Oxford Texbook of Medicine — Fourth Edition — Volume 3. Oxford. pp. 1170. ISBN 0-19852787-X. 

·  ^ Téllez-Zenteno JF, Hernández-Ronquillo L, Salinas V, Estanol B, da Silva O (2004). "Myasthenia gravis and pregnancy: clinical implications and neonatal outcome". BMC Musculoskeletal Disorders5: 42. doi:10.1186/1471-2474-5-42. PMID 15546494. PMC: 534111. http://www.biomedcentral.com/1471-2474/5/42. Retrieved on 2008-07-10. 

·  ^ Losen M, Martínez-Martínez P, Phernambucq M, Schuurman J, Parren PW, DE Baets MH (2008). "Treatment of myasthenia gravis by preventing acetylcholine receptor modulation". Ann N Y Acad Sci 1132: 174–9. doi:10.1196/annals.1405.034. PMID 18567867. 

·  ^ Juel VC. (2004). "Myasthenia gravis: management of myasthenic crisis and perioperative care.". Semin Neurol 24 (1): 75–81. doi:10.1055/s-2004-829595. PMID 15229794. 

·  ^ Calhoun R, et al. (1999). "Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients.". Annals of Surgery 230 (4): 555–561. doi:10.1097/00000658-199910000-00011. PMID 10522725. 

·  ^ "What is Myasthenia Gravis (MG)?". Myasthenia Gravis Foundation of America. http://www.myasthenia.org/amg_whatismg.cfm.

^ "Myopathy - Definition from the Merriam-Webster Online Dictionary". http://www.merriam-webster.com/dictionary/Myopathy. 
·  ^ a b c d e L. A. Colvin. Raj's Practical Management of Pain.BJA Advance Access published on December 1, 2000, DOI 10.1093/bja/aen312.Br. J. Anaesth. 101: 119-127.

·  ^ a b c d e Stechison, Michael. Personal INTERVIEW. 18 November 2008.

·  ^ a b c d Gilron I, Watson CPN, Cahill CM, Moulin DE. 2006. Neuropathic pain: a practical guide for the clinician. Canadian Medical Association Journal 175:265-75

·  ^ a b c Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, et al. 2003. Advances in neuropathic pain - Diagnosis, mechanisms, and treatment recommendations. Archives of Neurology, 60:1524-34

·  ^ a b Jensen TS. 2002. An improved understanding of neuropathic pain. European Journal of Pain-London, 6:3-11

·  ^ a b c d Daniel HC, Narewska J, Serpell M, Hoggart B, Johnson R, Rice ASC. 2008. Comparison of psychological and physical function in neuropathic pain and nociceptive pain: Implications for cognitive behavioral pain management programs. European Journal of Pain 12:731-41

·  ^ Garcia-Larrea L. 2008. Laser-evoked potentials in the diagnosis of central neuropathic pain. Douleur Et Analgesie 21:93-8

·  ^ Galer BS. 1995. Neuropathic pain of peripheral origin: Advances in pharmacologic treatment. Neurology 45:S17-S25

·  ^ Breivik H. 2002. Advances in treatment of neuropathic pain. European Journal of Pain-London 6:V-V

·  ^ Backonja. 2004. Defining neuropathic pain (vol 97, pg 785, 2003). Anesthesia and Analgesia 98:67

·  ^ Sherriff, Robert Cedric (1983). Journey's end. Harmondsworth [Eng.]: Penguin. pp. 53–58. ISBN 014 11 8326 8.

^ C. M. Fraser et al (July 1998). "Complete Genome Sequence of Treponema pallidum, the Syphilis Spirochete". Science 281 (5375): 375–388. doi:10.1126/science.281.5375.375. http://www.sciencemag.org/cgi/content/abstract/281/5375/375. 
^ "Syphilis Genome Sequence Offers Clues to Better Diagnosis, Prevention and Treatment". National Institute of Allergy and Infectious Diseases (NIAID). 1998. http://www3.niaid.nih.gov/news/newsreleases/1998/syphilis.htm. 
^ "Syphilis". Online Etymology Dictionary. 2001. http://www.etymonline.com/. 
^ Rudy's List of Archaic Medical Terms (2007-04-27). ""B"". Antiquus Morbus. http://www.antiquusmorbus.com/English/EnglishB.htm. Retrieved on 2008-04-28. 
Referencing:
Robley Dunglison (1874). Dunglison's Medical Dictionary – A Dictionary of Medical Science. Philadelphia, USA: Collins. 
^ Keys D (2007). "English syphilis epidemic pre-dated European outbreaks by 150 years". Independent News and Media Limited. http://news.independent.co.uk/health/article266422.ece. Retrieved on 2007-09-22. 
^ Henneberg M, Henneberg RJ (1994). "Treponematosis in an Ancient Greek colony of Metaponto, Southern Italy 580-250 BCE". in O Dutour, G Palfi, J Berato, J-P Brun (eds). The Origin of Syphilis in Europe, Before or After 1493?. Toulon-Paris: Centre Archeologique du Var, Editions Errance. pp. 92–98. 
^ Henneberg M, Henneberg RJ (2002). "Reconstructing Medical Knowledge in Ancient Pompeii from the Hard Evidence of Bones and Teeth". in J Renn, G Castagnetti (eds). Homo Faber: Studies on Nature. Technology and Science at the Time of Pompeii,. Rome: "L’ERMA" di Bretschneider. pp. pp.169–187. 
^ Rose M (January/February 1997). "Origins of Syphilis". Archaeology 50 (1). http://www.archaeology.org/9701/newsbriefs/syphilis.html. 
^ Baker, et al.[citation needed]
^ Debora MacKenzie (15 January 2008). "Columbus blamed for spread of syphilis". NewScientist. http://www.newscientist.com/article/dn13186-columbus-blamed-for-spread-of-syphilis-.html. 
^ Harper KN, Ocampo PS, Steiner BM, et al (2008). "On the origin of the treponematoses: a phylogenetic approach". PLoS Negl Trop Dis 2 (1): e148. doi:10.1371/journal.pntd.0000148. PMID 18235852. http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0000148. 
^ a b ref:225 Crosby[citation needed]
^ a b c Lobdell J, Owsley D (August 1974). "The origin of syphilis". Journal of Sex Research 10 (1): 76–79.  (via JSTOR)
^ The Metropolitan Museum of Art Bulletin, Summer 2007, pp. 55-56.
^ "Noguchi, Hideyo". The Columbia Encyclopedia (Sixth Edition ed.). http://www.bartleby.net/65/no/NoguchiH.html. 
^ Wilson, A. G. (2001). Tolstoy: A Biography. New York: Norton. ISBN 0-393-32122-3. 
^ Lerner V, Finkelstein Y, Witztum E (June 2004). "The enigma of Lenin's (1870-1924) malady". Eur. J. Neurol. 11 (6): 371–6. doi:10.1111/j.1468-1331.2004.00839.x. PMID 15171732. http://www.blackwell-synergy.com/action/showFullText?submitFullText=Full+Text+HTML&doi=10.1111%2Fj.1468-1331.2004.00839.x. 
^ Oriel, J.D. (1994). The Scars of Venus: A History of Venereology. London: Springer-Verlag. 
^ Diamond, Jared (1997). Guns, Germs and Steel. New York: W.W. Norton. pp. 210. 
^ "Genetic Study Bolsters Columbus Link to Syphilis", New York Times, January 15, 2008
^ "Columbus May Have Brought Syphilis to Europe", LiveScience
^ Tithonus, Pednuad, J.. "Eugen Sandow - Father of Bodybuilding". The Human Marvels. http://thehumanmarvels.com/blog/?p=138. Retrieved on 2008-09-17. "At the time of his death in 1925, a cover story was released stating Sandow died prematurely at age 58 of a stroke shortly after pushing his car out of the mud. The actual cause of death was more likely due to complications from syphilis." [unreliable source?]
^ a b c d Pickering LK, ed. (2006), "Syphilis", Red Book, Elk Grove Village, IL: American Academy of Pediatrics, pp. 631–644 
^ Centers for Disease Control (CDC) (05-2004). "STD Facts - Syphilis". Centers for Disease Control. http://www.cdc.gov/std/syphilis/STDFact-Syphilis.htm. Retrieved on 2007-05-30. 
^ Dylewski J, Duong M (2 January 2007). "The rash of secondary syphilis". CMAJ. 176 (1): 33–5. doi:10.1503/cmaj.060665. PMID 17200385. 
^ Clark EG, Danbolt N (1964). "The Oslo study of the natural course of untreated syphilis: An epidemiologic investigation based on a re-study of the Boeck-Bruusgaard material". Med Clin North Am. 48: 613. 
^ Sapira JD (April 1981). "Quincke, de Musset, Duroziez, and Hill: some aortic regurgitations". South. Med. J. 74 (4): 459–67. PMID 7013091. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0038-4348&volume=74&issue=4&spage=459. 
^ Richard B. Jamess, MD, PhD (2002). "Syphilis- Sexually Transmitted Infections, 2006.". Sexually transmitted diseases treatment guidelines. 
^ Walter T, Lebouche B, Miailhes P, et al. (2006). "Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients". Clin Infect Dis 43 (6): 787–90. doi:10.1086/507099. PMID 16912958. 
^ How can Syphilis be Prevented?, Centers for Disease Control and Prevention
^ Hanlon M (7 June 2007). "The magical properties of Mercury, the metal the EU wants to ban". The Daily Mail. http://www.dailymail.co.uk/pages/live/articles/news/news.html?in_article_id=460406&in_page_id=1770. Retrieved on 2007-08-07. 
^ Thomas James Walker (December 4 1869). "The Treatment of Syphilis by the Hypodermic Injection of the Salts of Mercury". Br Med J. 2 (466): 605–608. 
^ Ozuah, Philip O. (March 2000), "Mercury poisoning", Current Problems in Pediatrics 30 (3): 91-99 [91] 
^ Brown, Kevin (2006). The Pox: The Life and Near Death of a Very Social Disease. Stroud: WSutton. pp. 85–111, 185–91. 
^ Centers for Disease Control (08-04-2006). "Sexually Transmitted Diseases Treatment Guidelines, 2006". MMWR 55 (RR-11): 24–32. 
^ Lukehart SA, Godornes C, Molini BJ, et al (July 2004). "Macrolide resistance in Treponema pallidum in the United States and Ireland". N. Engl. J. Med. 351 (2): 154–8. doi:10.1056/NEJMoa040216. PMID 15247355. 
^ Mitchell SJ, Engelman J, Kent CK, Lukehart SA, Godornes C, Klausner JD (February 2006). "Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004". Clin. Infect. Dis. 42 (3): 337–45. doi:10.1086/498899. PMID 16392078. 
^ Rolfs RT, Joesoef MR, Hendershot EF, et al (July 1997). "A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group". N. Engl. J. Med. 337 (5): 307–14. doi:10.1056/NEJM199707313370504. PMID 9235493. http://content.nejm.org/cgi/content/full/337/5/307. 
^ "A A World. Reference Room. Articles. Tuskegee Syphilis Study". http://www.pbs.org/wnet/aaworld/reference/articles/tuskegee_syphilis_study.html. Retrieved on 2007-08-07. 
^ Johannes Stradanus undated brief review of works hosted at the University of York in the United Kingdom. Accessed August 6, 2007.
^ Jan van der Straet's "Preparation..." at commercial art site. Accessed August 6, 2007.
^ wikisource:es:Historia de la vida del Buscón: Libro Primero: Capítulo III: continues with [...] porque se le había comido de unas búas de resfriado, que aun no fueron de vicio porque cuestan dinero;: "[...] because it had been eaten by the bubons of a cold, which were not of vice because they cost money;".
^ "O Mist�rio da Estrada de Sintra". http://www.filmesfundo.com/omisteriodaestradadesintra. Retrieved on 2007-08-07. 
^ http://www.ucolick.org/~randi/aecom/syphilis.txt
·  ^ a b c d e f Aminoff MJ, Greenberg DA, Simon RP (2005). Clinical Neurology (6th ed.). Lange: McGraw-Hill Medical. pp. 241–5. ISBN 0071423605. 

·  ^ Tuite PJ, Krawczewski K (2007). "Parkinsonism: a review-of-systems approach to diagnosis". Seminars in neurology 27 (2): 113–22. doi:10.1055/s-2007-971174. PMID 17390256. 

·  ^ Christine CW, Aminoff MJ (2004). "Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance". Am. J. Med. 117 (6): 412–9. doi:10.1016/j.amjmed.2004.03.032. PMID 15380498. 

·  ^ Tse W, Cersosimo MG, Gracies JM, et al (2004). "Movement disorders and AIDS: a review". Parkinsonism Relat. Disord. 10 (6): 323–34. doi:10.1016/j.parkreldis.2004.03.001. PMID 15261874. 

·  ^ Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D (2006). "Movement disorders and Creutzfeldt-Jakob disease: a review". Parkinsonism Relat. Disord. 12 (2): 65–71. doi:10.1016/j.parkreldis.2005.10.004. PMID 16364674. 

·  ^ Watanabe Y, Himeda T, Araki T (2005). "Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease" (PDF). Med. Sci. Monit. 11 (1): RA17–23. PMID 15614202. http://www.medscimonit.com/pub/vol_11/no_1/5333.pdf. 

·  ^ Wenning GK, Geser F (2003). "Multiple system atrophy". Rev. Neurol. (Paris) 159 (5 Pt 2): 3S31–8. PMID 12773886. 

·  ^ Uc EY, Rodnitzky RL (2003). "Childhood dystonia". Seminars in pediatric neurology 10 (1): 52–61. doi:10.1016/S1071-9091(02)00010-4. PMID 12785748. 

·  ^ a b c DeLong MR, Juncos JL (2004). Parkinson's Disease and Other Movement Disorders. In: Harrison's Principles of Internal Medicine (16th ed.). McGraw-Hill Professional. pp. 2414. ISBN 0-07-140235-7. 

·  ^ Dinis-Oliveira RJ, Remião F, Carmo H, et al (2006). "Paraquat exposure as an etiological factor of Parkinson's disease". Neurotoxicology 27 (6): 1110–22. doi:10.1016/j.neuro.2006.05.012. PMID 16815551. 

·  ^ Thanvi B, Lo N, Robinson T (2005). "Vascular Parkinsonism--an important cause of parkinsonism in older people" (PDF). Age and ageing 34 (2): 114–9. doi:10.1093/ageing/afi025. PMID 15713855. http://ageing.oxfordjournals.org/cgi/reprint/34/2/114. 

·  ^ Członkowska A, Tarnacka B, Möller JC, et al (2007). "Unified Wilson's Disease Rating Scale — a proposal for the neurological scoring of Wilson's disease patients". Neurol. Neurochir. Pol. 41 (1): 1–12. PMID 17330175.

^ vi_1/p/PHAKOMATOSIS article at GE's Medcyclopaedia
^ Enersen, Ole Daniel. "Jan van der Hoeve". Who Named It?. http://www.whonamedit.com/doctor.cfm/792.html. Retrieved on 2007-07-13. 
1147863071 at GPnotebook
KidsHealth
·  ^ "Peripheral Neuropathy Fact Sheet: National Institute of Neurological Disorders and Stroke (NINDS)". http://www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm. Retrieved on 2008-11-30. 

·  ^ Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ (1997). "Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies". Neurology 49 (6): 1635–40. PMID 9409359. 

·  ^ Kiziltan ME, Akalin MA, Sahin R, Uluduz D (2007). "Peripheral neuropathy in patients with diabetes mellitus presenting as Bell's palsy". Neuroscience Letters 427: 138. doi:10.1016/j.neulet.2007.09.029. PMID 17933462. 

·  ^ Cohen JS (December 2001). "Peripheral Neuropathy Associated with Fluoroquinolones" (PDF). Ann Pharmacother 35 (12): 1540–7. doi:10.1345/aph.1Z429. PMID 11793615. http://fqvictims.org/fqvictims/News/neuropathy/Neuropathy.pdf. 

·  ^ Gonzalez-Duarte A, Cikurel K, Simpson DM (2007). "Managing HIV peripheral neuropathy". Current HIV/AIDS reports 4 (3): 114–8. doi:10.1007/s11904-007-0017-6. PMID 17883996. 

·  ^ Wilkes G (2007). "Peripheral neuropathy related to chemotherapy". Seminars in oncology nursing 23 (3): 162–73. doi:10.1016/j.soncn.2007.05.001. PMID 17693343. 

·  ^ Liu N, Varma S, Tsao D, Shooter EM, Tolwani RJ (2007). "Depleting endogenous neurotrophin-3 enhances myelin formation in the Trembler-J mouse, a model of a peripheral neuropathy". J. Neurosci. Res. 85 (13): 2863–9. doi:10.1002/jnr.21388. PMID 17628499.

^ Genes and Disease at nlm.nih.gov - Gives a concise description of SCA, along with a picture of shrunken degenerated cerebellum.
^ sca1 at NIH/UW GeneTests
^ sca2 at NIH/UW GeneTests
^ sca3 at NIH/UW GeneTests
^ machado_joseph at NINDS
^ sca6 at NIH/UW GeneTests
^ sca7 at NIH/UW GeneTests
^ sca8 at NIH/UW GeneTests
^ sca10 at NIH/UW GeneTests
^ sca12 at NIH/UW GeneTests
^ sca14 at NIH/UW GeneTests
^ juvenile spinal muscular atrophy at Dorland's Medical Dictionary
^ a b AJHG - Rare Missense andVariants in UBE1 Are Associated with X-Linked Infantile Spinal Muscular Atrophy
^ Years-Long Search Unlocks Deadly Genetic Disease
^ Pearn JH, Hudgson P, Walton JN (December 1978). "A clinical and genetic study of spinal muscular atrophy of adult onset: the autosomal recessive form as a discrete disease entity". Brain 101 (4): 591–606. PMID 737522. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=737522. 
^ Pearn J (September 1978). "Autosomal dominant spinal muscular atrophy: a clinical and genetic study". J. Neurol. Sci. 38 (2): 263–75. PMID 712386. 
^ Pearn J, Bundley S, Carter CO, Wilson J, Gardner-Medwin D, Walton JN (July 1978). "A genetic study of subacute and chronic spinal muscular atrophy in childhood. A nosological analysis of 124 index patients". J. Neurol. Sci. 37 (3): 227–48. PMID 681978. 
^ Teo, Jasmine (19 December 2008). "Chew has muscular atrophy" (in English). The Straits Times. http://www.straitstimes.com/Breaking%2BNews/Singapore/Story/STIStory_316507.html. Retrieved on 2008-12-22. 
^ BBC NEWS | Health | Life of sick baby 'intolerable'
^ BBC NEWS | Health | Sick baby's family thanks judge
^ Specialists' reactions
1093992459 at GPnotebook
14-182d. at Merck Manual of Diagnosis and Therapy Professional Edition
·  ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0. 

·  ^ Brewis M, Poskanzer DC, Rolland C, et al, "Neurological disease in an English city". Acta Neurologica Scand Suppl 24:1--89, 1966.

·  ^ "Neurosurgical considerations in posttraumatic syringomyelia - Home Study Program". AORN Journal. January 2003. http://findarticles.com/p/articles/mi_m0FSL/is_1_77/ai_97058864. Retrieved on 2009-02-12. 

·  ^ Greenberg, David A, et al: Clinical Neurology. 5th ed. Feb 9, 2002.

·  ^ Nishida, Takayasu, et al. "A large bladder stone caused by syringomyelia". Japanese Journal of Clinical Urology, Vol.60, No. 6, pp 413-415, 2006. ISSN:0385-2393.

·  ^ "Information about a Genetic Research Study for Chiari Type I Malformation (CMI) with or without Syringomyelia."

·  ^ Yeom JS, Lee CK, Park KW, et al (2007). "Scoliosis associated with syringomyelia: analysis of MRI and curve progression". Eur Spine J 16 (10): 1629–35. doi:10.1007/s00586-007-0472-1. PMID 17701226.

·  ^ Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol. 1991;44(11):1147-57.

·  ^ The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24 Suppl 1:9-160.

·  ^ http://www.mayoclinic.com/health/tension-headache/DS00304

·  ^ Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomized crossover trial. Lancet. 1999 Jan 23;353:287-9

·  ^ Ashina S, Bendtsen L, Ashina M. Pathophysiology of tension-type headache. Curr Pain Headache Rep, 2005 Dec; 9:415-22.

·  ^ Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain. 2005 Nov;118:215-23.

·  ^ Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW (May 2001). "Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial". JAMA 285 (17): 2208–15. doi:10.1001/jama.285.17.2208. PMID 11325322. PMC: 2128735. http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=11325322. 

·  ^ de Ru JA, Buwalda J (June 2008). "Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache". J Laryngol Otol 123: 1–6. doi:10.1017/S0022215108003198. PMID 18588738. 

·  ^ Nestoriuc Y, Rief W, Martin A (June 2008). "Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators". J Consult Clin Psychol 76 (3): 379–96. doi:10.1037/0022-006X.76.3.379. PMID 18540732. 

·  ^ Rains JC (May 2008). "Change mechanisms in EMG biofeedback training: cognitive changes underlying improvements in tension headache". Headache 48 (5): 735–6; discussion 736–7. doi:10.1111/j.1526-4610.2008.01119_1.x. PMID 18471128. 

·  ^ Yurekli VA, Akhan G, Kutluhan S, Uzar E, Koyuncuoglu HR, Gultekin F (February 2008). "The effect of sodium valproate on chronic daily headache and its subgroups". J Headache Pain 9 (1): 37–41. doi:10.1007/s10194-008-0002-5. PMID 18231713. 

·  ^ Davis MA, Kononowech RW, Rolin SA, Spierings EL (May 2008). "Acupuncture for Tension-Type Headache: A Meta-Analysis of Randomized, Controlled Trials". J Pain 9: 667. doi:10.1016/j.jpain.2008.03.011. PMID 18499526. 

·  ^ Fernández-de-las-Peñas C, Alonso-Blanco C, Cuadrado ML, Miangolarra JC, Barriga FJ, Pareja JA (2006). "Are manual therapies effective in reducing pain from tension-type headache?: a systematic review". Clin J Pain 22 (3): 278–85. doi:10.1097/01.ajp.0000173017.64741.86. PMID 16514329. 

·  ^ Biondi DM (2005). "Physical treatments for headache: a structured review". Headache 45 (6): 738–46. doi:10.1111/j.1526-4610.2005.05141.x. PMID 15953306. 

·  ^ Bronfort G, Nilsson N, Haas M et al. (2004). "Non-invasive physical treatments for chronic/recurrent headache". Cochrane Database Syst Rev (3): CD001878. doi:10.1002/14651858.CD001878.pub2. PMID 15266458. 

·  ^ Ernst E, Canter PH (2006). "A systematic review of systematic reviews of spinal manipulation". J R Soc Med 99 (4): 192–6. doi:10.1258/jrsm.99.4.192. PMID 16574972. http://www.jrsm.org/cgi/content/full/99/4/192. 

·  ^ a b c Ernst E (2007). "Adverse effects of spinal manipulation: a systematic review". J R Soc Med 100 (7): 330–8. doi:10.1258/jrsm.100.7.330. PMID 17606755. http://www.jrsm.org/cgi/content/full/100/7/330. 

·  ^ Thiel HW, Bolton JE, Docherty S, Portlock JC (2007). "Safety of chiropractic manipulation of the cervical spine: a prospective national survey". Spine 32 (21): 2375–8. doi:10.1097/BRS.0b013e3181557bb1. PMID 17906581. 

·  ^ Anderson-Peacock E, Blouin JS, Bryans R et al. (2005). "Chiropractic clinical practice guideline: evidence-based treatment of adult neck pain not due to whiplash" (PDF). J Can Chiropr Assoc 49 (3): 158–209. http://www.jcca-online.org/Client/cca/jcca.nsf/objects/jcca-v49-3-158/$file/jcca-v49-3-158.pdf.  • Anderson-Peacock E, Bryans B, Descarreaux M et al. (2008). "A clinical practice guideline update from The CCA•CFCREAB-CPG" (PDF). J Can Chiropr Assoc 52 (1): 7–8. http://www.jcca-online.org/Client/cca/JCCA.nsf/objects/JCCA_March_2008_52_1/$file/jcca-v52-1-007.pdf. 

·  ^ Hurwitz EL, Carragee EJ, van der Velde G et al. (2008). "Treatment of neck pain: noninvasive interventions: results of the Bone and Joint Decade 2000–2010 Task Force on Neck Pain and Its Associated Disorders". Spine 33 (4 Suppl): S123–52. doi:10.1097/BRS.0b013e3181644b1d (inactive 2008-06-24). PMID 18204386. 

·  ^ Miley ML, Wellik KE, Wingerchuk DM, Demaerschalk BM (2008). "Does cervical manipulative therapy cause vertebral artery dissection and stroke?". Neurologist 14 (1): 66–73. doi:10.1097/NRL.0b013e318164e53d. PMID 18195663.

^ Online 'Mendelian Inheritance in Man' (OMIM) Zellweger syndrome; ZS -214100
^ GeneReviews: Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum
^ Krause C, Rosewich H, Thanos M, Gärtner J (2006). "Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients". Hum. Mutat. 27 (11): 1157. doi:10.1002/humu.9462. PMID 17041890. 
^ synd/1670 at Who Named It?
Based on zellweger at NINDS